Skip to main content
Top
Published in: BMC Medical Genetics 1/2005

Open Access 01-12-2005 | Debate

Theories of schizophrenia: a genetic-inflammatory-vascular synthesis

Authors: Daniel R Hanson, Irving I Gottesman

Published in: BMC Medical Genetics | Issue 1/2005

Login to get access

Abstract

Background

Schizophrenia, a relatively common psychiatric syndrome, affects virtually all brain functions yet has eluded explanation for more than 100 years. Whether by developmental and/or degenerative processes, abnormalities of neurons and their synaptic connections have been the recent focus of attention. However, our inability to fathom the pathophysiology of schizophrenia forces us to challenge our theoretical models and beliefs. A search for a more satisfying model to explain aspects of schizophrenia uncovers clues pointing to genetically mediated CNS microvascular inflammatory disease.

Discussion

A vascular component to a theory of schizophrenia posits that the physiologic abnormalities leading to illness involve disruption of the exquisitely precise regulation of the delivery of energy and oxygen required for normal brain function. The theory further proposes that abnormalities of CNS metabolism arise because genetically modulated inflammatory reactions damage the microvascular system of the brain in reaction to environmental agents, including infections, hypoxia, and physical trauma. Damage may accumulate with repeated exposure to triggering agents resulting in exacerbation and deterioration, or healing with their removal.
There are clear examples of genetic polymorphisms in inflammatory regulators leading to exaggerated inflammatory responses. There is also ample evidence that inflammatory vascular disease of the brain can lead to psychosis, often waxing and waning, and exhibiting a fluctuating course, as seen in schizophrenia. Disturbances of CNS blood flow have repeatedly been observed in people with schizophrenia using old and new technologies. To account for the myriad of behavioral and other curious findings in schizophrenia such as minor physical anomalies, or reported decreased rates of rheumatoid arthritis and highly visible nail fold capillaries, we would have to evoke a process that is systemic such as the vascular and immune/inflammatory systems.

Summary

A vascular-inflammatory theory of schizophrenia brings together environmental and genetic factors in a way that can explain the diversity of symptoms and outcomes observed. If these ideas are confirmed, they would lead in new directions for treatments or preventions by avoiding inducers of inflammation or by way of inflammatory modulating agents, thus preventing exaggerated inflammation and consequent triggering of a psychotic episode in genetically predisposed persons.
Appendix
Available only for authorised users
Literature
1.
go back to reference Faust D: The Limits of Scientific Reasoning. 1984, Minneapolis: University of Minnesota Press Faust D: The Limits of Scientific Reasoning. 1984, Minneapolis: University of Minnesota Press
2.
go back to reference Wicker A: Getting out of our conceptual ruts: strategies for expanding conceptual frameworks. Am Psychol. 1985, 40: 1094-1103. 10.1037//0003-066X.40.10.1094. Wicker A: Getting out of our conceptual ruts: strategies for expanding conceptual frameworks. Am Psychol. 1985, 40: 1094-1103. 10.1037//0003-066X.40.10.1094.
3.
go back to reference Gottesman II, Shields J, Hanson DR: Schizophrenia: the epigenetic puzzle. 1982, Cambridge: Cambridge University Press Gottesman II, Shields J, Hanson DR: Schizophrenia: the epigenetic puzzle. 1982, Cambridge: Cambridge University Press
4.
go back to reference Manji H, Gottesman II, Gould T: Signal transduction and genes-to-behaviors pathways in psychiatric diseases. Sci STKE. 2004, 207: Pe49- Manji H, Gottesman II, Gould T: Signal transduction and genes-to-behaviors pathways in psychiatric diseases. Sci STKE. 2004, 207: Pe49-
5.
go back to reference Petronis A: The origin of schizophrenia: Genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry. 2004, 55: 142-146. 10.1016/j.biopsych.2004.02.005. Petronis A: The origin of schizophrenia: Genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry. 2004, 55: 142-146. 10.1016/j.biopsych.2004.02.005.
6.
go back to reference Weinberger D, McClure R: Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?. Arch Gen Psychiatry. 2002, 59: 553-558. 10.1001/archpsyc.59.6.553.PubMed Weinberger D, McClure R: Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain?. Arch Gen Psychiatry. 2002, 59: 553-558. 10.1001/archpsyc.59.6.553.PubMed
7.
go back to reference Matthew A, Murray R: Schizophrenia: a neurodevelopmental or neurodegenerative disorder?. Curr Opin Psychiatry. 2002, 15: 9-15. 10.1097/00001504-200201000-00003. Matthew A, Murray R: Schizophrenia: a neurodevelopmental or neurodegenerative disorder?. Curr Opin Psychiatry. 2002, 15: 9-15. 10.1097/00001504-200201000-00003.
8.
go back to reference Lewis D, Levitt P: Schizophrenia as a disorder of neurodevelopment. Ann Rev Neurosci. 2002, 25: 409-432. 10.1146/annurev.neuro.25.112701.142754.PubMed Lewis D, Levitt P: Schizophrenia as a disorder of neurodevelopment. Ann Rev Neurosci. 2002, 25: 409-432. 10.1146/annurev.neuro.25.112701.142754.PubMed
9.
go back to reference Church S, Cotter D, Bramon E, Murray R: Does schizophrenia result from developmental or degenerative processes?. J Neural Transm Suppl. 2002, 63: 129-147.PubMed Church S, Cotter D, Bramon E, Murray R: Does schizophrenia result from developmental or degenerative processes?. J Neural Transm Suppl. 2002, 63: 129-147.PubMed
10.
go back to reference McGrath J, Feron F, Burne T, Mackay-Sim A, Eyles D: The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann Med. 2003, 35: 86-93. 10.1080/07853890310010005.PubMed McGrath J, Feron F, Burne T, Mackay-Sim A, Eyles D: The neurodevelopmental hypothesis of schizophrenia: a review of recent developments. Ann Med. 2003, 35: 86-93. 10.1080/07853890310010005.PubMed
11.
go back to reference Korenberg J, Kawashima H, Pulst S, Allen L, Magenis E, Epstein C: Down syndrome: toward a molecular definition of the phenotype. Am J Med Genet Suppl. 1990, 7: 91-97.PubMed Korenberg J, Kawashima H, Pulst S, Allen L, Magenis E, Epstein C: Down syndrome: toward a molecular definition of the phenotype. Am J Med Genet Suppl. 1990, 7: 91-97.PubMed
12.
go back to reference Opitz J, Gilbert-Barness E: Reflections on the pathogenesis of Down syndrome. Am J Hum Genet Suppl. 1990, 7: 38-51. Opitz J, Gilbert-Barness E: Reflections on the pathogenesis of Down syndrome. Am J Hum Genet Suppl. 1990, 7: 38-51.
13.
go back to reference Head E, Lott I: Down syndrome and beta-amyloid deposition. Curr Opin Neurol. 2004, 17: 95-100. 10.1097/00019052-200404000-00003.PubMed Head E, Lott I: Down syndrome and beta-amyloid deposition. Curr Opin Neurol. 2004, 17: 95-100. 10.1097/00019052-200404000-00003.PubMed
14.
go back to reference Bleuler E: Dementia Praecox or the Group of Schizophrenias. 1911, New York: International University Press Bleuler E: Dementia Praecox or the Group of Schizophrenias. 1911, New York: International University Press
15.
go back to reference Kraepelin E: Dementia Praecox and Paraphrenia. 1919, Edinburgh: E & S Livingston Kraepelin E: Dementia Praecox and Paraphrenia. 1919, Edinburgh: E & S Livingston
16.
go back to reference Kim-Cohen J, Caspi A, Moffitt TE, Harrington H, Milne BJ, Poulton R: Prior juvenile diagnoses in adults with mental disorder. Arch Gen Psychiatry. 2003, 60: 709-717. 10.1001/archpsyc.60.7.709.PubMed Kim-Cohen J, Caspi A, Moffitt TE, Harrington H, Milne BJ, Poulton R: Prior juvenile diagnoses in adults with mental disorder. Arch Gen Psychiatry. 2003, 60: 709-717. 10.1001/archpsyc.60.7.709.PubMed
17.
go back to reference Erlenmeyer-Kimling L: Neurobehavioral deficits in offspring of schizophrenic parents. Am J Med Genet. 2000, 97: 65-71. 10.1002/(SICI)1096-8628(200021)97:1<65::AID-AJMG9>3.0.CO;2-V.PubMed Erlenmeyer-Kimling L: Neurobehavioral deficits in offspring of schizophrenic parents. Am J Med Genet. 2000, 97: 65-71. 10.1002/(SICI)1096-8628(200021)97:1<65::AID-AJMG9>3.0.CO;2-V.PubMed
18.
go back to reference Niemi L, Suvisaari J, Tuulio-Henriksson A, Lonnqvist J: Childhood developmental abnormalities in schizophrenia: evidence from high risk studies. Schizophr Res. 2003, 60: 239-258. 10.1016/S0920-9964(02)00234-7.PubMed Niemi L, Suvisaari J, Tuulio-Henriksson A, Lonnqvist J: Childhood developmental abnormalities in schizophrenia: evidence from high risk studies. Schizophr Res. 2003, 60: 239-258. 10.1016/S0920-9964(02)00234-7.PubMed
19.
go back to reference Erlenmeyer-Kimling L, Roberts S, Rock D: Longitudinal prediction of schizophrenia in a prospective high-risk study. Behavior Genetic Principles: Perspectives in Development, Personality, and Psychopathology. Edited by: DiLalla LF. 2004, Washington, D.C.: American Psychological Association, 135-144. Erlenmeyer-Kimling L, Roberts S, Rock D: Longitudinal prediction of schizophrenia in a prospective high-risk study. Behavior Genetic Principles: Perspectives in Development, Personality, and Psychopathology. Edited by: DiLalla LF. 2004, Washington, D.C.: American Psychological Association, 135-144.
20.
go back to reference Hanson DR, Gottesman II: The genetics, if any, of infantile autism and childhood schizophrenia. J Autism Child Schizophr. 1976, 6: 209-234.PubMed Hanson DR, Gottesman II: The genetics, if any, of infantile autism and childhood schizophrenia. J Autism Child Schizophr. 1976, 6: 209-234.PubMed
21.
go back to reference Slater E, Cowie V: The Genetics of Mental Disorders. 1971, London: Oxford University Press Slater E, Cowie V: The Genetics of Mental Disorders. 1971, London: Oxford University Press
22.
go back to reference Cosway R, Byrne M, Clafferty R, Hodges A, Grant E, Abukmeil S, Lawrie S, Miller P, Johnstone E: Neuropsychological change in young people at high risk for schizophrenia: results from the fist two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med. 2000, 30: 1111-1121. 10.1017/S0033291799002585.PubMed Cosway R, Byrne M, Clafferty R, Hodges A, Grant E, Abukmeil S, Lawrie S, Miller P, Johnstone E: Neuropsychological change in young people at high risk for schizophrenia: results from the fist two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med. 2000, 30: 1111-1121. 10.1017/S0033291799002585.PubMed
23.
go back to reference Gunnell D, Harrison G, Rasmussen F, Fouskakis D, Tynelius P: Association between premorbid intellectual performance, early life exposures and early-onset schizophrenia. Br J Psychiatry. 2002, 181: 298-305. 10.1192/bjp.181.4.298.PubMed Gunnell D, Harrison G, Rasmussen F, Fouskakis D, Tynelius P: Association between premorbid intellectual performance, early life exposures and early-onset schizophrenia. Br J Psychiatry. 2002, 181: 298-305. 10.1192/bjp.181.4.298.PubMed
24.
go back to reference Friedman J, Harvey P, Coleman T, Moriarty P, Bowie C, Parrella M, white L, Adler D, Davis K: Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am J Psychiatry. 2001, 158: 1441-1448. 10.1176/appi.ajp.158.9.1441.PubMed Friedman J, Harvey P, Coleman T, Moriarty P, Bowie C, Parrella M, white L, Adler D, Davis K: Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. Am J Psychiatry. 2001, 158: 1441-1448. 10.1176/appi.ajp.158.9.1441.PubMed
25.
go back to reference Zammit S, Allebeck P, David A, Dlaman C, Hemmingsson T, Lundberg I, Lewis G: A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry. 2004, 61: 354-360. 10.1001/archpsyc.61.4.354.PubMed Zammit S, Allebeck P, David A, Dlaman C, Hemmingsson T, Lundberg I, Lewis G: A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses. Arch Gen Psychiatry. 2004, 61: 354-360. 10.1001/archpsyc.61.4.354.PubMed
26.
go back to reference Keri S, Janka Z: Critical evaluation of cognitive dysfunctions as endophenotypes of schizophrenia. Acta Psychiatr Scand. 2004, 110: 83-91. 10.1111/j.1600-0047.2004.00359.x.PubMed Keri S, Janka Z: Critical evaluation of cognitive dysfunctions as endophenotypes of schizophrenia. Acta Psychiatr Scand. 2004, 110: 83-91. 10.1111/j.1600-0047.2004.00359.x.PubMed
27.
go back to reference Keller A, Castellanos F, Vaituzis A, Jeffries N, Giedd J, Rapoport J: Progressive loss of cerebellar volume in childhood-onset schizophrenia. Am J Psychiatry. 2003, 160: 128-133. 10.1176/appi.ajp.160.1.128.PubMed Keller A, Castellanos F, Vaituzis A, Jeffries N, Giedd J, Rapoport J: Progressive loss of cerebellar volume in childhood-onset schizophrenia. Am J Psychiatry. 2003, 160: 128-133. 10.1176/appi.ajp.160.1.128.PubMed
28.
go back to reference Mathalon D, Sullivan E, Lim K, Pfefferbaum A: Progressive brain volume changes and the clinical course of schizophrenia. Arch Gen Psychiatry. 2001, 58: 148-157. 10.1001/archpsyc.58.2.148.PubMed Mathalon D, Sullivan E, Lim K, Pfefferbaum A: Progressive brain volume changes and the clinical course of schizophrenia. Arch Gen Psychiatry. 2001, 58: 148-157. 10.1001/archpsyc.58.2.148.PubMed
29.
go back to reference Niznikiewicz M, Kubicki M, Shenton M: Recent structural and functional imaging findings in schizophrenia. Curr Opin Psychiatry. 2003, 16: 123-147. 10.1097/00001504-200303000-00002. Niznikiewicz M, Kubicki M, Shenton M: Recent structural and functional imaging findings in schizophrenia. Curr Opin Psychiatry. 2003, 16: 123-147. 10.1097/00001504-200303000-00002.
30.
go back to reference Stevens J: Anatomy of schizophrenia revisited. Schizophr Bull. 1997, 23: 373-383.PubMed Stevens J: Anatomy of schizophrenia revisited. Schizophr Bull. 1997, 23: 373-383.PubMed
31.
go back to reference Garey L, Ong W, Patel T, Kanani M, Davis A, Mortimer A, Barnes T, Hirsch S: Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 1998, 65: 446-453.PubMedPubMedCentral Garey L, Ong W, Patel T, Kanani M, Davis A, Mortimer A, Barnes T, Hirsch S: Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 1998, 65: 446-453.PubMedPubMedCentral
32.
go back to reference Senitz D, Winkelmann E: Neuronal strukturanormalitat im orbito-frontalen cortex bei schizophrenien. J Hirnforsch. 1991, 32: 149-158.PubMed Senitz D, Winkelmann E: Neuronal strukturanormalitat im orbito-frontalen cortex bei schizophrenien. J Hirnforsch. 1991, 32: 149-158.PubMed
33.
go back to reference Picchini A, Manji H, Gould T: GSK-3 and neurotropic signaling: novel targets underlying the pathophysioplogy and treatment of mood disorders?. Drug Discovery Today: Disease Mechanisms. 2004, 1: 419-428. 10.1016/j.ddmec.2004.11.020. Picchini A, Manji H, Gould T: GSK-3 and neurotropic signaling: novel targets underlying the pathophysioplogy and treatment of mood disorders?. Drug Discovery Today: Disease Mechanisms. 2004, 1: 419-428. 10.1016/j.ddmec.2004.11.020.
34.
go back to reference Cotter D, Pariante C, Everall I: Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull. 2001, 55: 589-595. 10.1016/S0361-9230(01)00527-5. Cotter D, Pariante C, Everall I: Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull. 2001, 55: 589-595. 10.1016/S0361-9230(01)00527-5.
35.
go back to reference Rosenthal D: The Genain Quadruplets: A Case Study and Theoretical Analysis of Heredity and Environment in Schizophrenia. 1963, New York: Basic Books Rosenthal D: The Genain Quadruplets: A Case Study and Theoretical Analysis of Heredity and Environment in Schizophrenia. 1963, New York: Basic Books
36.
go back to reference Bleuler M: The Schizophrenic Disorders: Long-term Patient and Family Studies. 1978, New Haven: Yale University Press Bleuler M: The Schizophrenic Disorders: Long-term Patient and Family Studies. 1978, New Haven: Yale University Press
37.
go back to reference Schiffman J, Ekstrom M, La Brie J, Schulsinger F, Sorensen H, Mednick S: Minor physical anomalies and schizophrenia spectrum disorders: a prospective investigation. Am J Psychiatry. 2002, 159: 238-243. 10.1176/appi.ajp.159.2.238.PubMed Schiffman J, Ekstrom M, La Brie J, Schulsinger F, Sorensen H, Mednick S: Minor physical anomalies and schizophrenia spectrum disorders: a prospective investigation. Am J Psychiatry. 2002, 159: 238-243. 10.1176/appi.ajp.159.2.238.PubMed
38.
go back to reference McNeil TF, Cantor-Graae E: Minor physical anomalies and obstetric complication in schizophrenia. Aust N Z J Psychiatry. 2000, 34: S65-73. 10.1046/j.1440-1614.2000.00784.x.PubMed McNeil TF, Cantor-Graae E: Minor physical anomalies and obstetric complication in schizophrenia. Aust N Z J Psychiatry. 2000, 34: S65-73. 10.1046/j.1440-1614.2000.00784.x.PubMed
39.
go back to reference Hata K, Iida J, Iwasaka H, Negoro H, Kishimoto T: Association between minor physical anomalies and lateral ventricular enlargement in childhood and adolescent schizophrenia. Acta Psychiatr Scand. 2003, 108: 147-151. 10.1034/j.1600-0447.2003.00116.x.PubMed Hata K, Iida J, Iwasaka H, Negoro H, Kishimoto T: Association between minor physical anomalies and lateral ventricular enlargement in childhood and adolescent schizophrenia. Acta Psychiatr Scand. 2003, 108: 147-151. 10.1034/j.1600-0447.2003.00116.x.PubMed
40.
go back to reference Guy J, Majorski L, Wallace C, Guy M: The incidence of minor physical anomalies in adult male schizophrenics. Schizophr Bull. 1983, 9: 571-582.PubMed Guy J, Majorski L, Wallace C, Guy M: The incidence of minor physical anomalies in adult male schizophrenics. Schizophr Bull. 1983, 9: 571-582.PubMed
41.
go back to reference Buckley P: The clinical stigmata of aberrant neurodevelopment in schizophrenia. J Nerv Ment Dis. 1998, 186: 79-86. 10.1097/00005053-199802000-00003.PubMed Buckley P: The clinical stigmata of aberrant neurodevelopment in schizophrenia. J Nerv Ment Dis. 1998, 186: 79-86. 10.1097/00005053-199802000-00003.PubMed
42.
go back to reference Hennesy R, Lane A, Kinsella A, Larkin C, O'Callaghan E, Waddington J: 3D morphometrics of craniofacial dysmorphology reveals sex-specific asymmetries in schizophrenia. Schizophr Res. 2004, 67: 261-268. 10.1016/j.schres.2003.08.003. Hennesy R, Lane A, Kinsella A, Larkin C, O'Callaghan E, Waddington J: 3D morphometrics of craniofacial dysmorphology reveals sex-specific asymmetries in schizophrenia. Schizophr Res. 2004, 67: 261-268. 10.1016/j.schres.2003.08.003.
43.
go back to reference Maricq H: Capillary pattern in familial schizophrenics: a study of nailfold capillaries. Circulation. 1963, 27: 406-413. Maricq H: Capillary pattern in familial schizophrenics: a study of nailfold capillaries. Circulation. 1963, 27: 406-413.
44.
go back to reference Curtis CE, Iacono WG, Beiser M: Relationships between nailfold plexus visibility and clinical, neuropsychological, and brain structural measures in schizophrenia. Biol Psychiatry. 1999, 46: 102-109. 10.1016/S0006-3223(98)00363-1.PubMed Curtis CE, Iacono WG, Beiser M: Relationships between nailfold plexus visibility and clinical, neuropsychological, and brain structural measures in schizophrenia. Biol Psychiatry. 1999, 46: 102-109. 10.1016/S0006-3223(98)00363-1.PubMed
45.
go back to reference Vinogradov S, Gottesman II, Moises HW, Nicol S: Negative association between schizophrenia and rheumatoid arthritis. Schizophr Bull. 1991, 17: 669-678.PubMed Vinogradov S, Gottesman II, Moises HW, Nicol S: Negative association between schizophrenia and rheumatoid arthritis. Schizophr Bull. 1991, 17: 669-678.PubMed
46.
go back to reference Cardno A, Gottesman II: Twin studies of schizophrenia: from bow-and-arrow concordance to Star Wars Mx and functional genomics. Am J Med Genet. 2000, 97: 12-17.PubMed Cardno A, Gottesman II: Twin studies of schizophrenia: from bow-and-arrow concordance to Star Wars Mx and functional genomics. Am J Med Genet. 2000, 97: 12-17.PubMed
47.
go back to reference Hanson DR: Getting the bugs into our genetic theories of schizophrenia. Behavior Genetic Principals Perspectives in Development, Personality, and Psychopathology. Edited by: DiLalla L. 2004, Washington, D.C.: American Psychiatric Press, 205-216. Hanson DR: Getting the bugs into our genetic theories of schizophrenia. Behavior Genetic Principals Perspectives in Development, Personality, and Psychopathology. Edited by: DiLalla L. 2004, Washington, D.C.: American Psychiatric Press, 205-216.
48.
go back to reference Meehl P: Specific etiology and other forms of strong influence: Some quantitative meanings. J Med and Philos. 1977, 2: 33-53. Meehl P: Specific etiology and other forms of strong influence: Some quantitative meanings. J Med and Philos. 1977, 2: 33-53.
50.
go back to reference Yolken RH, Karlsson H, Yee F, Torrey EF: Endogenous retroviruses and schizophrenia. Brain Res Rev. 2000, 31: 193-199. 10.1016/S0165-0173(99)00037-5.PubMed Yolken RH, Karlsson H, Yee F, Torrey EF: Endogenous retroviruses and schizophrenia. Brain Res Rev. 2000, 31: 193-199. 10.1016/S0165-0173(99)00037-5.PubMed
51.
go back to reference Harrison P: The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain. 1999, 122: 593-624. 10.1093/brain/122.4.593.PubMed Harrison P: The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain. 1999, 122: 593-624. 10.1093/brain/122.4.593.PubMed
52.
go back to reference Rothermundt M, Arolt V, Bayer T: Review of immunological and immunopathological finding in schizophrenia. Brain Behav Immun. 2001, 15: 319-339. 10.1006/brbi.2001.0648.PubMed Rothermundt M, Arolt V, Bayer T: Review of immunological and immunopathological finding in schizophrenia. Brain Behav Immun. 2001, 15: 319-339. 10.1006/brbi.2001.0648.PubMed
53.
go back to reference Rothermundt M, Peters M, Prehn J, Arolt V: S100B in brain damage and neurodegeneration. Microsc Res Tech. 2003, 60: 614-632. 10.1002/jemt.10303.PubMed Rothermundt M, Peters M, Prehn J, Arolt V: S100B in brain damage and neurodegeneration. Microsc Res Tech. 2003, 60: 614-632. 10.1002/jemt.10303.PubMed
54.
go back to reference Rothermundt M, Ponath G, Arolt V: S100B in schizophrenic psychosis. Int Rev Neurobiol. 2004, 59: 445-470.PubMed Rothermundt M, Ponath G, Arolt V: S100B in schizophrenic psychosis. Int Rev Neurobiol. 2004, 59: 445-470.PubMed
55.
go back to reference Rothermundt M, Falaki P, Ponath G, Abel S, Burkle H, Diedrich M, Hetzel G, Peters M, Siegmund A, Pedersen A, et al: Glial cell dysfunction in schizophrenia indicate by increased S100B in the CSF. Mol Psychiatry. 2004, 9: 897-899. 10.1038/sj.mp.4001548.PubMed Rothermundt M, Falaki P, Ponath G, Abel S, Burkle H, Diedrich M, Hetzel G, Peters M, Siegmund A, Pedersen A, et al: Glial cell dysfunction in schizophrenia indicate by increased S100B in the CSF. Mol Psychiatry. 2004, 9: 897-899. 10.1038/sj.mp.4001548.PubMed
56.
go back to reference Pellerin S, Therianos S, Magistretti P: The metabolic function of glial cells. Glial Cell Development. Edited by: Jessen K, Richardson W. 2001, Oxford: Oxford University Press, 91-107. 2 Pellerin S, Therianos S, Magistretti P: The metabolic function of glial cells. Glial Cell Development. Edited by: Jessen K, Richardson W. 2001, Oxford: Oxford University Press, 91-107. 2
57.
go back to reference Kurosinski P, Gotz J: Glial cells under physiologic and pathologic conditions. Arch Neurol. 2002, 59: 1524-1528. 10.1001/archneur.59.10.1524.PubMed Kurosinski P, Gotz J: Glial cells under physiologic and pathologic conditions. Arch Neurol. 2002, 59: 1524-1528. 10.1001/archneur.59.10.1524.PubMed
58.
go back to reference Haydon P: GLIA: listening and talking to the synapse. Nat Rev Neurosci. 2001, 2: 185-193. 10.1038/35058528.PubMed Haydon P: GLIA: listening and talking to the synapse. Nat Rev Neurosci. 2001, 2: 185-193. 10.1038/35058528.PubMed
59.
go back to reference Coyle J, Schwarcz R: Mind glue: implications of glial cell biology for psychiatry. Arch Gen Psychiatry. 2000, 57: 90-93. 10.1001/archpsyc.57.1.90.PubMed Coyle J, Schwarcz R: Mind glue: implications of glial cell biology for psychiatry. Arch Gen Psychiatry. 2000, 57: 90-93. 10.1001/archpsyc.57.1.90.PubMed
60.
go back to reference Zonta M, Angulo M, Gobbo S, Rosengarten B, Hossmann K, Pozzan T, Carmignoto G: Neuron-to-astrocyte signaling is central to dynamic control of brain microcirculation. Nat Neurosci. 2003, 6: 43-50. 10.1038/nn980.PubMed Zonta M, Angulo M, Gobbo S, Rosengarten B, Hossmann K, Pozzan T, Carmignoto G: Neuron-to-astrocyte signaling is central to dynamic control of brain microcirculation. Nat Neurosci. 2003, 6: 43-50. 10.1038/nn980.PubMed
61.
go back to reference Medhora M, Narayanan J, Harder D: Dual regulation of the cerebral microvasculature by epoxyeicosatrienoic acids. Trends Cardiovasc Med. 2001, 11: 38-42. 10.1016/S1050-1738(01)00082-2.PubMed Medhora M, Narayanan J, Harder D: Dual regulation of the cerebral microvasculature by epoxyeicosatrienoic acids. Trends Cardiovasc Med. 2001, 11: 38-42. 10.1016/S1050-1738(01)00082-2.PubMed
62.
go back to reference Abott N: Astrocyte-endothelial interactions and blood-brain permeability. J Anatomy. 2002, 200: 629-638. 10.1046/j.1469-7580.2002.00064.x. Abott N: Astrocyte-endothelial interactions and blood-brain permeability. J Anatomy. 2002, 200: 629-638. 10.1046/j.1469-7580.2002.00064.x.
63.
go back to reference Virgintino D, Robertson D, Errede M, Benagiano V, Tauer U, Roncali L, Bertossi M: Expression of caveolin-1 in human brain microvessels. Neuroscience. 2002, 115: 145-152. 10.1016/S0306-4522(02)00374-3.PubMed Virgintino D, Robertson D, Errede M, Benagiano V, Tauer U, Roncali L, Bertossi M: Expression of caveolin-1 in human brain microvessels. Neuroscience. 2002, 115: 145-152. 10.1016/S0306-4522(02)00374-3.PubMed
64.
go back to reference Paulson O: Blood-brain barrier, brain metabolism and cerebral blood flow. Eur Neuropsychopharmacol. 2002, 12: 465-501. 10.1016/S0924-977X(02)00098-6. Paulson O: Blood-brain barrier, brain metabolism and cerebral blood flow. Eur Neuropsychopharmacol. 2002, 12: 465-501. 10.1016/S0924-977X(02)00098-6.
65.
go back to reference Yoder E: Modifications in astrocyte morphology and calcium signaling induced by a brain capillary endothelial cell line. Glia. 2002, 38: 137-145. 10.1002/glia.10016.PubMed Yoder E: Modifications in astrocyte morphology and calcium signaling induced by a brain capillary endothelial cell line. Glia. 2002, 38: 137-145. 10.1002/glia.10016.PubMed
66.
go back to reference Gallo V, Ghiani C, Yuan X: The role of ion channels and neurotransmitter receptors in glial cell development. Glial Cell Development. Edited by: Jessen K, Richardson W. 2001, Oxford: Oxford University Press, 110-130. 2 Gallo V, Ghiani C, Yuan X: The role of ion channels and neurotransmitter receptors in glial cell development. Glial Cell Development. Edited by: Jessen K, Richardson W. 2001, Oxford: Oxford University Press, 110-130. 2
67.
go back to reference Harder D, Zhang C, Gebremedhin D: Astrocytes function in matching blood flow to metabolic activity. News Physiol Sci. 2002, 17: 27-31.PubMed Harder D, Zhang C, Gebremedhin D: Astrocytes function in matching blood flow to metabolic activity. News Physiol Sci. 2002, 17: 27-31.PubMed
68.
go back to reference Cohen Z, Bouchelet I, Olivier A, Villemure J, Ball R, Stanimirovic D, Hamel E: Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. J Cereb Blood Flow Metab. 1999, 19: 908-917. 10.1097/00004647-199908000-00010.PubMed Cohen Z, Bouchelet I, Olivier A, Villemure J, Ball R, Stanimirovic D, Hamel E: Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. J Cereb Blood Flow Metab. 1999, 19: 908-917. 10.1097/00004647-199908000-00010.PubMed
69.
go back to reference Elhusseiny A, Cohen Z, Olivier A, Stanimirovic D, Hamel E: Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization. J Cereb Blood Flow Metab. 1999, 19: 794-802. 10.1097/00004647-199907000-00010.PubMed Elhusseiny A, Cohen Z, Olivier A, Stanimirovic D, Hamel E: Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization. J Cereb Blood Flow Metab. 1999, 19: 794-802. 10.1097/00004647-199907000-00010.PubMed
70.
go back to reference Favard C, Simon A, Vigny A, Nguyen-Legros J: Ultrastructural evidence for a close relationship between dopamine cell process and blood capillary walls in Macaca monkey and rat retina. Brain Res. 1990, 523: 127-133. 10.1016/0006-8993(90)91645-W.PubMed Favard C, Simon A, Vigny A, Nguyen-Legros J: Ultrastructural evidence for a close relationship between dopamine cell process and blood capillary walls in Macaca monkey and rat retina. Brain Res. 1990, 523: 127-133. 10.1016/0006-8993(90)91645-W.PubMed
71.
go back to reference Bacic F, Uematsu S, McCarron RM, Spatz M: Dopamine receptors linked to adenylate cyclase in human cerebromicrovascular endothelium. J Neurochem. 1991, 57: 1774-1780.PubMed Bacic F, Uematsu S, McCarron RM, Spatz M: Dopamine receptors linked to adenylate cyclase in human cerebromicrovascular endothelium. J Neurochem. 1991, 57: 1774-1780.PubMed
72.
go back to reference Cavaglia M, Dombrowski S, Drazba J, Vasanji A, Bokesch P, Janigro D: Regional variation in brain capillary density and vascular response to ischemia. Brain Res. 2001, 910: 81-93. 10.1016/S0006-8993(01)02637-3.PubMed Cavaglia M, Dombrowski S, Drazba J, Vasanji A, Bokesch P, Janigro D: Regional variation in brain capillary density and vascular response to ischemia. Brain Res. 2001, 910: 81-93. 10.1016/S0006-8993(01)02637-3.PubMed
73.
go back to reference Harrison R, Harel N, Panesar J, Mount R: Blood capillary distribution correlates with hemodynamic-based functional imaging in cerebral cortex. Cereb Cortex. 2002, 12: 225-233. 10.1093/cercor/12.3.225.PubMed Harrison R, Harel N, Panesar J, Mount R: Blood capillary distribution correlates with hemodynamic-based functional imaging in cerebral cortex. Cereb Cortex. 2002, 12: 225-233. 10.1093/cercor/12.3.225.PubMed
74.
go back to reference Risau W, Esser S, Engelhardt B: Differentiation of blood-brain barrier endothelial cells. Pathol Biol. 1998, 46: 171-175.PubMed Risau W, Esser S, Engelhardt B: Differentiation of blood-brain barrier endothelial cells. Pathol Biol. 1998, 46: 171-175.PubMed
75.
go back to reference Sasaki R: Pleiotropic functions of erythropoietin. Intern Med. 2003, 42: 142-149.PubMed Sasaki R: Pleiotropic functions of erythropoietin. Intern Med. 2003, 42: 142-149.PubMed
76.
go back to reference Shusta EV, Boado RJ, Mathern GW, Pardridge WM: Vascular genomics of the human brain. J Cereb Blood Flow Metab. 2002, 22: 245-252. 10.1097/00004647-200203000-00001.PubMed Shusta EV, Boado RJ, Mathern GW, Pardridge WM: Vascular genomics of the human brain. J Cereb Blood Flow Metab. 2002, 22: 245-252. 10.1097/00004647-200203000-00001.PubMed
77.
go back to reference Virgintino D, Errede M, Robertson D, Girolamo F, Masciandaro A, Bertossi M: VEGF expression is developmentally regulated during brain angiogenesis. Histochem Cell Biol. 2003, 119: 227-232.PubMed Virgintino D, Errede M, Robertson D, Girolamo F, Masciandaro A, Bertossi M: VEGF expression is developmentally regulated during brain angiogenesis. Histochem Cell Biol. 2003, 119: 227-232.PubMed
78.
go back to reference Schiera G, Bono E, Raffa MP, Gallo A, Pitarresi GL, Di Liegro I, Savett G: Synergistic effects of neurons and astrocytes on the differentiation of brain capillary endothelial cells in culture. J Cell Mol Med. 2003, 7: 165-170.PubMed Schiera G, Bono E, Raffa MP, Gallo A, Pitarresi GL, Di Liegro I, Savett G: Synergistic effects of neurons and astrocytes on the differentiation of brain capillary endothelial cells in culture. J Cell Mol Med. 2003, 7: 165-170.PubMed
79.
go back to reference Zhang C, Harder DR: Cerebral capillary endothelial cell mitogenesis and morphogenesis induced by astrocyte epoxyeicosartrienoic acid. Stroke. 2002, 33: 2957-2964. 10.1161/01.STR.0000037787.07479.9A.PubMed Zhang C, Harder DR: Cerebral capillary endothelial cell mitogenesis and morphogenesis induced by astrocyte epoxyeicosartrienoic acid. Stroke. 2002, 33: 2957-2964. 10.1161/01.STR.0000037787.07479.9A.PubMed
80.
go back to reference Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, Kim YJ, Kim K: SSeCKS regulates angiogenesis and tight junction formation in the blood-brain barrier. Nat Med. 2003, 9: 828-829. 10.1038/nm0703-828. Lee SW, Kim WJ, Choi YK, Song HS, Son MJ, Gelman IH, Kim YJ, Kim K: SSeCKS regulates angiogenesis and tight junction formation in the blood-brain barrier. Nat Med. 2003, 9: 828-829. 10.1038/nm0703-828.
81.
go back to reference Senitz D, Benninghoff J: Histomorphology of angiogenesis in human perinatal orbitofrontal cortex: a Golgi and electron microscopic study of anastomosis formation. Anat Embryol. 2003, 206: 479-485.PubMed Senitz D, Benninghoff J: Histomorphology of angiogenesis in human perinatal orbitofrontal cortex: a Golgi and electron microscopic study of anastomosis formation. Anat Embryol. 2003, 206: 479-485.PubMed
82.
go back to reference Richter T, Ronald P: The evolution of disease resistant genes. Plant Mol Biol. 2000, 42: 195-204. 10.1023/A:1006388223475.PubMed Richter T, Ronald P: The evolution of disease resistant genes. Plant Mol Biol. 2000, 42: 195-204. 10.1023/A:1006388223475.PubMed
83.
go back to reference Mackenzie K, Bishop S: Utilizing stochastic genetic epidemiological models to quantify the impact of selection for resistance to infectious diesease in domestic livestock. J Anim Sci. 2001, 79: 2057-2065.PubMed Mackenzie K, Bishop S: Utilizing stochastic genetic epidemiological models to quantify the impact of selection for resistance to infectious diesease in domestic livestock. J Anim Sci. 2001, 79: 2057-2065.PubMed
84.
go back to reference Kallmann FJ, Reisner D: Twin studies on the genetic variation in resistance to tuberculosis. J Hered. 1943, 34: 293-301. Kallmann FJ, Reisner D: Twin studies on the genetic variation in resistance to tuberculosis. J Hered. 1943, 34: 293-301.
85.
go back to reference Werneck-Barroso E: Innate resistance to tuberculosis: revisiting Max Lurie genetic experiments in rabbits. Int J Tuberc Lung Dis. 1999, 3: 166-168.PubMed Werneck-Barroso E: Innate resistance to tuberculosis: revisiting Max Lurie genetic experiments in rabbits. Int J Tuberc Lung Dis. 1999, 3: 166-168.PubMed
86.
go back to reference McGue M, Gottesman II, Rao DC: The transmission of schizophrenia under a multifactorial threshold model. Am J Hum Genet. 1983, 35: 1161-1178.PubMedPubMedCentral McGue M, Gottesman II, Rao DC: The transmission of schizophrenia under a multifactorial threshold model. Am J Hum Genet. 1983, 35: 1161-1178.PubMedPubMedCentral
87.
go back to reference Bion JF, Brun-Buisson C: Introduction – infection and critical illness: genetic and environmental aspects of susceptibility and resistance. Intensive Care Med. 2000, S1-S2. Supplement 1 Bion JF, Brun-Buisson C: Introduction – infection and critical illness: genetic and environmental aspects of susceptibility and resistance. Intensive Care Med. 2000, S1-S2. Supplement 1
88.
go back to reference Burt RA: Genetics of host response to malaria. Int J Parasitol. 1999, 29: 973-979. 10.1016/S0020-7519(99)00054-5.PubMed Burt RA: Genetics of host response to malaria. Int J Parasitol. 1999, 29: 973-979. 10.1016/S0020-7519(99)00054-5.PubMed
89.
go back to reference Hawken RJ, Beattie CW, Schook LB: Resolving the genetics of resistance to infectious diseases. Rev Sci Tech. 1998, 17: 17-25.PubMed Hawken RJ, Beattie CW, Schook LB: Resolving the genetics of resistance to infectious diseases. Rev Sci Tech. 1998, 17: 17-25.PubMed
90.
go back to reference Hill AV: Genetics of infectious disease resistance. Curr Opin Genet Dev. 1996, 6: 348-353. 10.1016/S0959-437X(96)80013-X.PubMed Hill AV: Genetics of infectious disease resistance. Curr Opin Genet Dev. 1996, 6: 348-353. 10.1016/S0959-437X(96)80013-X.PubMed
91.
go back to reference Hill AV: Genetics and genomics of infectious disease susceptibility. Br Med Bull. 1999, 55: 401-413. 10.1258/0007142991902457.PubMed Hill AV: Genetics and genomics of infectious disease susceptibility. Br Med Bull. 1999, 55: 401-413. 10.1258/0007142991902457.PubMed
92.
go back to reference Seymour RM: Some aspects of the coevolution of virulence and resistance in contact transmission processes with ecological constraints. IMA J Math Appl Med Biol. 1995, 12: 83-136.PubMed Seymour RM: Some aspects of the coevolution of virulence and resistance in contact transmission processes with ecological constraints. IMA J Math Appl Med Biol. 1995, 12: 83-136.PubMed
93.
go back to reference Kitagawa M, Aizawa S, Ikeda H, Hirokawa W: Establishment of a therapeutic model for retroviral infection using the genetic resistance mechanism of the host. Pathol Int. 1996, 46: 719-725.PubMed Kitagawa M, Aizawa S, Ikeda H, Hirokawa W: Establishment of a therapeutic model for retroviral infection using the genetic resistance mechanism of the host. Pathol Int. 1996, 46: 719-725.PubMed
94.
95.
go back to reference Blackwell JM: Genetics and genomics of infectious disease susceptibility. Trends Mol Med. 2001, 7: 521-526. 10.1016/S1471-4914(01)02169-4.PubMed Blackwell JM: Genetics and genomics of infectious disease susceptibility. Trends Mol Med. 2001, 7: 521-526. 10.1016/S1471-4914(01)02169-4.PubMed
96.
go back to reference Knight J: Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious disease and the septic shock syndrome. Curr Infect Dis Rep. 2001, 3: 427-439.PubMed Knight J: Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious disease and the septic shock syndrome. Curr Infect Dis Rep. 2001, 3: 427-439.PubMed
97.
go back to reference Cook GS, Hill AV: Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001, 2: 967-977. 10.1038/35103577. Cook GS, Hill AV: Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001, 2: 967-977. 10.1038/35103577.
98.
go back to reference Beskow AH, Gyllensten UB: Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer. 2002, 101: 526-531. 10.1002/ijc.90010.PubMed Beskow AH, Gyllensten UB: Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer. 2002, 101: 526-531. 10.1002/ijc.90010.PubMed
99.
go back to reference Wang FS: Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol. 2003, 9: 641-644.PubMedPubMedCentral Wang FS: Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol. 2003, 9: 641-644.PubMedPubMedCentral
100.
go back to reference Touitou I: The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet. 2001, 473-483. 10.1038/sj.ejhg.5200658. Touitou I: The spectrum of Familial Mediterranean Fever (FMF) mutations. Eur J Hum Genet. 2001, 473-483. 10.1038/sj.ejhg.5200658.
101.
go back to reference Scholl P: Periodic fever syndromes. Curr Opin Pediatr. 2000, 12: 563-566. 10.1097/00008480-200012000-00009.PubMed Scholl P: Periodic fever syndromes. Curr Opin Pediatr. 2000, 12: 563-566. 10.1097/00008480-200012000-00009.PubMed
102.
go back to reference Ozen S: Vasculopathy, Bechets Syndrome and familial Mediterranean fever. Curr Opin Rheumatol. 1999, 11: 393-398. 10.1097/00002281-199909000-00011.PubMed Ozen S: Vasculopathy, Bechets Syndrome and familial Mediterranean fever. Curr Opin Rheumatol. 1999, 11: 393-398. 10.1097/00002281-199909000-00011.PubMed
103.
go back to reference Tutar E, Akar N, Atalay S, Yilmaz E, Akar E, Yalcinkaya F: Familial Mediterranean fever gene (MEFV) mutations in patients with rheumatic heart disease. Heart. 2002, 87: 568-569.PubMedPubMedCentral Tutar E, Akar N, Atalay S, Yilmaz E, Akar E, Yalcinkaya F: Familial Mediterranean fever gene (MEFV) mutations in patients with rheumatic heart disease. Heart. 2002, 87: 568-569.PubMedPubMedCentral
104.
go back to reference Veasy LG, Hill HR: Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J. 1997, 16: 400-407. 10.1097/00006454-199704000-00012.PubMed Veasy LG, Hill HR: Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J. 1997, 16: 400-407. 10.1097/00006454-199704000-00012.PubMed
105.
go back to reference Yegin O, Coskun M, Ertug H: Cytokines in acute rheumatic fever. Eur J Pediatr. 1997, 156: 25-29.PubMed Yegin O, Coskun M, Ertug H: Cytokines in acute rheumatic fever. Eur J Pediatr. 1997, 156: 25-29.PubMed
106.
go back to reference Shore P, Jackson E, Wisniewski S, Clark R, Adelson P, Kochanek P: Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children. Neurosurgery. 2004, 54: 605-611. 10.1227/01.NEU.0000108642.88724.DB.PubMed Shore P, Jackson E, Wisniewski S, Clark R, Adelson P, Kochanek P: Vascular endothelial growth factor is increased in cerebrospinal fluid after traumatic brain injury in infants and children. Neurosurgery. 2004, 54: 605-611. 10.1227/01.NEU.0000108642.88724.DB.PubMed
107.
go back to reference Curristin S, Cao A, Stewart W, Zhang H, Madri J, Morrow J, Ment L: Disrupted synaptic development in the hypoxic newborn brain. Proc Natl Acad Sci USA. 2002, 99: 15729-15734. 10.1073/pnas.232568799.PubMedPubMedCentral Curristin S, Cao A, Stewart W, Zhang H, Madri J, Morrow J, Ment L: Disrupted synaptic development in the hypoxic newborn brain. Proc Natl Acad Sci USA. 2002, 99: 15729-15734. 10.1073/pnas.232568799.PubMedPubMedCentral
108.
go back to reference Zang W, Smith C, Howlett C, Stanimirovic D: Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1[beta]. J Cereb Blood Flow Metab. 2000, 20: 967-978. Zang W, Smith C, Howlett C, Stanimirovic D: Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1[beta]. J Cereb Blood Flow Metab. 2000, 20: 967-978.
109.
go back to reference Dietrich P-Y, Walker P, Saas P: Death receptors on reactive astrocytes: a key role in the fine tuning of brain inflammation. Neurology. 2003, 60: 548-554.PubMed Dietrich P-Y, Walker P, Saas P: Death receptors on reactive astrocytes: a key role in the fine tuning of brain inflammation. Neurology. 2003, 60: 548-554.PubMed
110.
go back to reference Meeuwsen S, Persoon-Dean C, Bsibis M, Ravid R, Van Noort J: Cytokine, chemokine, and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia. 2003, 43: 243-253. 10.1002/glia.10259.PubMed Meeuwsen S, Persoon-Dean C, Bsibis M, Ravid R, Van Noort J: Cytokine, chemokine, and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia. 2003, 43: 243-253. 10.1002/glia.10259.PubMed
111.
go back to reference Croitoru-Lamoury J, Guillemin G, Boussin F, Mognetti B, Gigout L, Cheret A, Vaslin B, LeGrand R, Brew B, Dormont D: Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNFα and IFNγ in CXCR4 and CCR5 modulation. Glia. 2003, 41: 354-370. 10.1002/glia.10181.PubMed Croitoru-Lamoury J, Guillemin G, Boussin F, Mognetti B, Gigout L, Cheret A, Vaslin B, LeGrand R, Brew B, Dormont D: Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNFα and IFNγ in CXCR4 and CCR5 modulation. Glia. 2003, 41: 354-370. 10.1002/glia.10181.PubMed
112.
go back to reference Rubenstein G: Schizophrenia, rheumatoid arthritis and natural disease resistance. Schizophr Res. 1997, 25: 177-181. Rubenstein G: Schizophrenia, rheumatoid arthritis and natural disease resistance. Schizophr Res. 1997, 25: 177-181.
113.
go back to reference Morris JA: Schizophrenia, bacterial toxins and the genetics of redundancy. Med Hypotheses. 1996, 46: 362-366.PubMed Morris JA: Schizophrenia, bacterial toxins and the genetics of redundancy. Med Hypotheses. 1996, 46: 362-366.PubMed
114.
go back to reference Munk-Jorgensen P, Ewald H: Epidemiology in neurobiological research: exemplified by the influenza-schizophrenia story. Br J Psychiatry Suppl. 2001, 40: S30-S32. 10.1192/bjp.178.40.s30.PubMed Munk-Jorgensen P, Ewald H: Epidemiology in neurobiological research: exemplified by the influenza-schizophrenia story. Br J Psychiatry Suppl. 2001, 40: S30-S32. 10.1192/bjp.178.40.s30.PubMed
115.
go back to reference O'Reilly SL, Singh SM: Retroviruses and schizophrenia revisited. Am J Med Genet. 1996, 67: 19-26. 10.1002/(SICI)1096-8628(19960216)67:1<19::AID-AJMG3>3.0.CO;2-N.PubMed O'Reilly SL, Singh SM: Retroviruses and schizophrenia revisited. Am J Med Genet. 1996, 67: 19-26. 10.1002/(SICI)1096-8628(19960216)67:1<19::AID-AJMG3>3.0.CO;2-N.PubMed
116.
go back to reference Torrey EF, Miller J, Rawlings R, Yolken RH: Seasonality of births in schizophrenia and bipolar disorder: A review of the research. Schizophr Res. 1997, 28: 1-38. 10.1016/S0920-9964(97)00092-3.PubMed Torrey EF, Miller J, Rawlings R, Yolken RH: Seasonality of births in schizophrenia and bipolar disorder: A review of the research. Schizophr Res. 1997, 28: 1-38. 10.1016/S0920-9964(97)00092-3.PubMed
117.
go back to reference Davison K, Bagley C: Schizophrenia-like psychoses associated with organic disorders of the central nervous system: A review of the literature. Current Problems in Neuropsychiatry: Schizophrenia, Epilepsy, the Temporal Lobe. Edited by: Herrington R. 1969, Ashford, Kent, UK: Headley Brothers Davison K, Bagley C: Schizophrenia-like psychoses associated with organic disorders of the central nervous system: A review of the literature. Current Problems in Neuropsychiatry: Schizophrenia, Epilepsy, the Temporal Lobe. Edited by: Herrington R. 1969, Ashford, Kent, UK: Headley Brothers
118.
go back to reference Beadles C: On the degenerative lesions of the arterial system in the insane, with remarks upon the nature of the granular ependyma. J Ment Sci. 1895, 41: 32-50. Beadles C: On the degenerative lesions of the arterial system in the insane, with remarks upon the nature of the granular ependyma. J Ment Sci. 1895, 41: 32-50.
119.
go back to reference Bender L: Psychiatric, neurologic and neuropathologic studies in disseminated alterative arteriolitis. Arch Neurol Psychiatry. 1936, 36: 790-815. Bender L: Psychiatric, neurologic and neuropathologic studies in disseminated alterative arteriolitis. Arch Neurol Psychiatry. 1936, 36: 790-815.
120.
go back to reference Hess D: Cerebral lupus vasculopathy. Mechanisms and clinical relevance. Ann NY Acad Sci. 1997, 823: 154-168.PubMed Hess D: Cerebral lupus vasculopathy. Mechanisms and clinical relevance. Ann NY Acad Sci. 1997, 823: 154-168.PubMed
121.
go back to reference Lass P, et al: Cerebral blood flow in Sjogren's syndrome using 99Tcm-HMPAO brain SPET. Nucl Med Commun. 2000, 21: 31-35. 10.1097/00006231-200001000-00006.PubMed Lass P, et al: Cerebral blood flow in Sjogren's syndrome using 99Tcm-HMPAO brain SPET. Nucl Med Commun. 2000, 21: 31-35. 10.1097/00006231-200001000-00006.PubMed
122.
go back to reference Fredericks R, Lefkowitz D, Challa V, Troost B: Cerebral vasculitis associated with cocaine abuse. Stroke. 1991, 22: 1437-1439.PubMed Fredericks R, Lefkowitz D, Challa V, Troost B: Cerebral vasculitis associated with cocaine abuse. Stroke. 1991, 22: 1437-1439.PubMed
123.
go back to reference Shi X, Wu J, Liu Z, Tang J, Su Y: Single photon emission CT perfusion imaging of cerebral blood flow in early syphilis patients. Chin Med J (Engl). 2003, 116: 1051-1054. Shi X, Wu J, Liu Z, Tang J, Su Y: Single photon emission CT perfusion imaging of cerebral blood flow in early syphilis patients. Chin Med J (Engl). 2003, 116: 1051-1054.
124.
go back to reference Thomas A, et al: Ischemic basis for deep white matter hyperintensities in major depression. Arch Gen Psychiatry. 2002, 59: 785-792. 10.1001/archpsyc.59.9.785.PubMed Thomas A, et al: Ischemic basis for deep white matter hyperintensities in major depression. Arch Gen Psychiatry. 2002, 59: 785-792. 10.1001/archpsyc.59.9.785.PubMed
125.
go back to reference Kronfol Z, Remick DG: Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000, 157: 683-694. 10.1176/appi.ajp.157.5.683.PubMed Kronfol Z, Remick DG: Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry. 2000, 157: 683-694. 10.1176/appi.ajp.157.5.683.PubMed
126.
go back to reference Wang H, Yu M, Oschanl M, Amella C, Tanovic M, Susarla S, Li J, Wang H, Yang H, Ulloa L, et al: Nicotinic acetylcholine receptor alpha subunit is an essential regulator of inflammation. Nature. 2003, 421: 384-388. 10.1038/nature01339.PubMed Wang H, Yu M, Oschanl M, Amella C, Tanovic M, Susarla S, Li J, Wang H, Yang H, Ulloa L, et al: Nicotinic acetylcholine receptor alpha subunit is an essential regulator of inflammation. Nature. 2003, 421: 384-388. 10.1038/nature01339.PubMed
127.
go back to reference Chorsky R, Yaghamai F, Hill W, Stopa E: Alzheimer's disease: a review concerning immune response and microischemia. Med Hypotheses. 2001, 56: 124-127. 10.1054/mehy.2000.1148.PubMed Chorsky R, Yaghamai F, Hill W, Stopa E: Alzheimer's disease: a review concerning immune response and microischemia. Med Hypotheses. 2001, 56: 124-127. 10.1054/mehy.2000.1148.PubMed
128.
go back to reference Farkas E, De Jong G, Apro E, De Vos R, Steur E, Luiten P: Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension. What is the functional link?. Ann N Y Acad Sci. 2000, 903: 72-82.PubMed Farkas E, De Jong G, Apro E, De Vos R, Steur E, Luiten P: Similar ultrastructural breakdown of cerebrocortical capillaries in Alzheimer's disease, Parkinson's disease, and experimental hypertension. What is the functional link?. Ann N Y Acad Sci. 2000, 903: 72-82.PubMed
129.
go back to reference Farkas E, Luiten P: Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol. 2001, 64: 575-611. 10.1016/S0301-0082(00)00068-X.PubMed Farkas E, Luiten P: Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol. 2001, 64: 575-611. 10.1016/S0301-0082(00)00068-X.PubMed
130.
go back to reference Versijpt J, Van Laere K, Dierckx R, Dumont F, De Deyn P, Slegers G, Korf J: Scintigraphic visualization of inflammation in neurodegenerative disorders. Nucl Med Commun. 2003, 24: 209-221. 10.1097/00006231-200302000-00014.PubMed Versijpt J, Van Laere K, Dierckx R, Dumont F, De Deyn P, Slegers G, Korf J: Scintigraphic visualization of inflammation in neurodegenerative disorders. Nucl Med Commun. 2003, 24: 209-221. 10.1097/00006231-200302000-00014.PubMed
131.
go back to reference Grammas P: A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging. 2000, 21: 199-205. 10.1016/S0197-4580(00)00102-0.PubMed Grammas P: A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging. 2000, 21: 199-205. 10.1016/S0197-4580(00)00102-0.PubMed
132.
go back to reference de La Torre J: Critically attained threshold of cerebral hypoprofusion: Can it cause Alzheimer's disease?. Ann N Y Acad Sci. 2000, 903: 424-436.PubMed de La Torre J: Critically attained threshold of cerebral hypoprofusion: Can it cause Alzheimer's disease?. Ann N Y Acad Sci. 2000, 903: 424-436.PubMed
133.
go back to reference Preston S, Steart P, Wilkinson A, Nicoll J, Weller R: Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid [beta] from the human brain. Neuropathol Appl Neurobiol. 2003, 29: 106-117. 10.1046/j.1365-2990.2003.00424.x.PubMed Preston S, Steart P, Wilkinson A, Nicoll J, Weller R: Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid [beta] from the human brain. Neuropathol Appl Neurobiol. 2003, 29: 106-117. 10.1046/j.1365-2990.2003.00424.x.PubMed
134.
go back to reference Borroni B, Akkawi N, Martini G, Colciaghi F, Prometti P, Rozzinin L, Di Luca M, Lenzi G, Romanelli G, Caimi L, et al: Microvascular damage and platelet abnormalities in early Alzheimer's disease. J Neurol Sci. 2002, 203–204: 189-193. 10.1016/S0022-510X(02)00289-7.PubMed Borroni B, Akkawi N, Martini G, Colciaghi F, Prometti P, Rozzinin L, Di Luca M, Lenzi G, Romanelli G, Caimi L, et al: Microvascular damage and platelet abnormalities in early Alzheimer's disease. J Neurol Sci. 2002, 203–204: 189-193. 10.1016/S0022-510X(02)00289-7.PubMed
135.
go back to reference Vagnucci AHJ, Li WW: Alzheimer's disease and angiogenesis. Lancet. 2003, 361: 605-608. 10.1016/S0140-6736(03)12521-4.PubMed Vagnucci AHJ, Li WW: Alzheimer's disease and angiogenesis. Lancet. 2003, 361: 605-608. 10.1016/S0140-6736(03)12521-4.PubMed
136.
go back to reference Gibson C, MacLennan A, Goldwater P, Dekker G: Antenatal causes of cerebral palsy: associations between inherited thrombophilias, viral and bacterial infection, and inherited susceptibility to infection. Obstet Gynecol Surv. 2003, 58: 209-220. 10.1097/00006254-200303000-00024.PubMed Gibson C, MacLennan A, Goldwater P, Dekker G: Antenatal causes of cerebral palsy: associations between inherited thrombophilias, viral and bacterial infection, and inherited susceptibility to infection. Obstet Gynecol Surv. 2003, 58: 209-220. 10.1097/00006254-200303000-00024.PubMed
137.
go back to reference Lee Y, Henning B, Yao J, Toborek M: Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J Neurosci Res. 2001, 66: 583-591. 10.1002/jnr.1248.PubMed Lee Y, Henning B, Yao J, Toborek M: Methamphetamine induces AP-1 and NF-kappaB binding and transactivation in human brain endothelial cells. J Neurosci Res. 2001, 66: 583-591. 10.1002/jnr.1248.PubMed
138.
go back to reference Lignelli G, Buchheit W: Angitis in drug abusers. N Engl J Med. 1971, 284: 112-113. Lignelli G, Buchheit W: Angitis in drug abusers. N Engl J Med. 1971, 284: 112-113.
139.
go back to reference Rumbaugh C, Bergeron R, Fang H, McCormik R: Cerebral angiographic changes in the drug abuse patient. Radiology. 1971, 101: 335-344.PubMed Rumbaugh C, Bergeron R, Fang H, McCormik R: Cerebral angiographic changes in the drug abuse patient. Radiology. 1971, 101: 335-344.PubMed
140.
go back to reference Citron B, Halpern M, McCarron M, Lundberg G, McCormick R, Pincus I, Tatter D, Haverback B: Necrotizing angitis associate with drug abuse. N Engl J Med. 1970, 283: 1003-1011.PubMed Citron B, Halpern M, McCarron M, Lundberg G, McCormick R, Pincus I, Tatter D, Haverback B: Necrotizing angitis associate with drug abuse. N Engl J Med. 1970, 283: 1003-1011.PubMed
141.
go back to reference Behzadian MA, Wang XL, Shabrawey M, Caldwell RB: Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia. 1998, 24: 216-225.PubMed Behzadian MA, Wang XL, Shabrawey M, Caldwell RB: Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia. 1998, 24: 216-225.PubMed
142.
go back to reference Dammann O, Leviton A: Brain damage in preterm newborns: might enhancement of developmentally regulated endogenous protection open the door for prevention?. Pediatrics. 1999, 104: 541-550. 10.1542/peds.104.3.541.PubMed Dammann O, Leviton A: Brain damage in preterm newborns: might enhancement of developmentally regulated endogenous protection open the door for prevention?. Pediatrics. 1999, 104: 541-550. 10.1542/peds.104.3.541.PubMed
143.
go back to reference Molinero A, Penkowa M, Hernandez J, Camats J, Giralt M, Lago N, Carrasco J, Campbell IL: Matallothionein-I over expression decreased brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-g. J Neuropathol Exp Neurol. 2003, 62: 315-328.PubMed Molinero A, Penkowa M, Hernandez J, Camats J, Giralt M, Lago N, Carrasco J, Campbell IL: Matallothionein-I over expression decreased brain pathology in transgenic mice with astrocyte-targeted expression of interleukin-g. J Neuropathol Exp Neurol. 2003, 62: 315-328.PubMed
144.
go back to reference Proescholdt MA, Heiss JD, Walbridge S, Muhlhauser J, Capogrossi MC, Oldfield EH, Merrill MJ: Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol. 1999, 58: 613-627.PubMed Proescholdt MA, Heiss JD, Walbridge S, Muhlhauser J, Capogrossi MC, Oldfield EH, Merrill MJ: Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol. 1999, 58: 613-627.PubMed
145.
go back to reference Penkowa M, Carrasco J, Giralt M, Molinero A, Hernandez J, Campbell IL, Hidalgo J: Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallotioein-I=II deficient mice. J Cereb Blood Flow Metab. 2000, 20: 1174-1189. 10.1097/00004647-200008000-00003.PubMed Penkowa M, Carrasco J, Giralt M, Molinero A, Hernandez J, Campbell IL, Hidalgo J: Altered central nervous system cytokine-growth factor expression profiles and angiogenesis in metallotioein-I=II deficient mice. J Cereb Blood Flow Metab. 2000, 20: 1174-1189. 10.1097/00004647-200008000-00003.PubMed
146.
go back to reference Kirk SL, Karlik SJ: VEGF and vascular changes in chronic neuroinflammation. J Autoimmun. 2003, 21: 353-363. 10.1016/S0896-8411(03)00139-2.PubMed Kirk SL, Karlik SJ: VEGF and vascular changes in chronic neuroinflammation. J Autoimmun. 2003, 21: 353-363. 10.1016/S0896-8411(03)00139-2.PubMed
147.
go back to reference Olsen NV: Central nervous system frontiers for the use of erythropoietin. Clin Infect Dis. 2003, 37: S323-S330. 10.1086/376912.PubMed Olsen NV: Central nervous system frontiers for the use of erythropoietin. Clin Infect Dis. 2003, 37: S323-S330. 10.1086/376912.PubMed
148.
go back to reference Yang RB, Ng CK, Wasserman SM, Colman SD, Shenoy S, Mehraban F, Komuves LG, Tomlinson JE, Topper JN: Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J Biol Chem. 2002, 277: 46364-46373. 10.1074/jbc.M207410200.PubMed Yang RB, Ng CK, Wasserman SM, Colman SD, Shenoy S, Mehraban F, Komuves LG, Tomlinson JE, Topper JN: Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. J Biol Chem. 2002, 277: 46364-46373. 10.1074/jbc.M207410200.PubMed
149.
go back to reference Cannon M, Jones P, Murray RM: Obstetric complications and schizophrenia: Historical and meta-analytic review. Am J Psychiatry. 2002, 159: 1080-1092. 10.1176/appi.ajp.159.7.1080.PubMed Cannon M, Jones P, Murray RM: Obstetric complications and schizophrenia: Historical and meta-analytic review. Am J Psychiatry. 2002, 159: 1080-1092. 10.1176/appi.ajp.159.7.1080.PubMed
150.
go back to reference Gilmore J, Jarskog L, Vadlamudi S, Lauder J: Prenatal infection and risk for schizophrenia: IL-Iβ, IL-6, and TNFα inhibit cortical neuron dendrite development. Neuropsychopharmacology. 2004, 29: 1221-1229. 10.1038/sj.npp.1300446.PubMed Gilmore J, Jarskog L, Vadlamudi S, Lauder J: Prenatal infection and risk for schizophrenia: IL-Iβ, IL-6, and TNFα inhibit cortical neuron dendrite development. Neuropsychopharmacology. 2004, 29: 1221-1229. 10.1038/sj.npp.1300446.PubMed
151.
go back to reference Mueller N, Riedel M, Hadjamu M, Schwarz M, Ackenheil M, Gruber R: Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia. Am J Psychiatry. 1999, 156: 634-636. Mueller N, Riedel M, Hadjamu M, Schwarz M, Ackenheil M, Gruber R: Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia. Am J Psychiatry. 1999, 156: 634-636.
152.
go back to reference Kety S, Schmidt C: The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest. 1948, 27: 476-483.PubMedPubMedCentral Kety S, Schmidt C: The nitrous oxide method for the quantitative determination of cerebral blood flow in man: theory, procedure and normal values. J Clin Invest. 1948, 27: 476-483.PubMedPubMedCentral
153.
go back to reference Kety SS, Woodford RB, Harmel MH, Freyman FA, Appel KE, Schmidt CF: Cerebral blood blow and metabolism in schizophrenia. Am J Psychiatry. 1948, 104: 765-770.PubMed Kety SS, Woodford RB, Harmel MH, Freyman FA, Appel KE, Schmidt CF: Cerebral blood blow and metabolism in schizophrenia. Am J Psychiatry. 1948, 104: 765-770.PubMed
154.
go back to reference Williamson P: Hypofrontality in schizophrenia: a review of the evidence. Can J Psychiatry. 1987, 32: 399-404.PubMed Williamson P: Hypofrontality in schizophrenia: a review of the evidence. Can J Psychiatry. 1987, 32: 399-404.PubMed
155.
go back to reference Weinberger DR, Berman KF: Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. Schizophr Bull. 1988, 14: 157-168.PubMed Weinberger DR, Berman KF: Speculation on the meaning of cerebral metabolic hypofrontality in schizophrenia. Schizophr Bull. 1988, 14: 157-168.PubMed
156.
go back to reference Semkovska M, Bedard MA, Stip E: Hypofrontalite et symptomes nefatifs dans la schizophrenie: syntheses des acquis anatomiques et neuropsychologiques et neuropsychologiques et perspectives ecologiques. Encephale. 2001, 27: 405-415.PubMed Semkovska M, Bedard MA, Stip E: Hypofrontalite et symptomes nefatifs dans la schizophrenie: syntheses des acquis anatomiques et neuropsychologiques et neuropsychologiques et perspectives ecologiques. Encephale. 2001, 27: 405-415.PubMed
157.
go back to reference Honey G, Fletcher P, Bullmore E: Functional brain mapping of psychopathology. J Neurol Neurosurg Psychiatry. 2002, 72: 432-439.PubMedPubMedCentral Honey G, Fletcher P, Bullmore E: Functional brain mapping of psychopathology. J Neurol Neurosurg Psychiatry. 2002, 72: 432-439.PubMedPubMedCentral
158.
go back to reference Hofer A, Weiss E: Advances in the neuroimaging of cognitive functions in schizophrenia. Curr Opin Psychiatry. 2002, 15: 3-7. 10.1097/00001504-200201000-00002. Hofer A, Weiss E: Advances in the neuroimaging of cognitive functions in schizophrenia. Curr Opin Psychiatry. 2002, 15: 3-7. 10.1097/00001504-200201000-00002.
159.
go back to reference Bachneff S: Regional cerebral blood flow in schizophrenia and the local circuit neurons hypothesis. Schizophr Bull. 1996, 22: 163-182.PubMed Bachneff S: Regional cerebral blood flow in schizophrenia and the local circuit neurons hypothesis. Schizophr Bull. 1996, 22: 163-182.PubMed
160.
go back to reference Andreasen N, O'Leary D, Flaum M, Nopoulos P, Watkins G, Ponto L, Hichwa R: Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet. 1997, 349: 1730-1734. 10.1016/S0140-6736(96)08258-X.PubMed Andreasen N, O'Leary D, Flaum M, Nopoulos P, Watkins G, Ponto L, Hichwa R: Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet. 1997, 349: 1730-1734. 10.1016/S0140-6736(96)08258-X.PubMed
161.
go back to reference Barch C, Carter C, Braver T, Sabb F, MacDonald A, Noll D, Cohen J: Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry. 2001, 58: 280-288. 10.1001/archpsyc.58.3.280.PubMed Barch C, Carter C, Braver T, Sabb F, MacDonald A, Noll D, Cohen J: Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry. 2001, 58: 280-288. 10.1001/archpsyc.58.3.280.PubMed
162.
go back to reference Kim JJ, Mohamed S, Andreasen NC, Oleary DS, Watkins GL, BolesPonto LL, Hichwa RD: Regional neural dysfunctions in chronic schizophrenia studied with positive emission tomography. Am J Psychiatry. 2000, 157: 542-548. 10.1176/appi.ajp.157.4.542.PubMed Kim JJ, Mohamed S, Andreasen NC, Oleary DS, Watkins GL, BolesPonto LL, Hichwa RD: Regional neural dysfunctions in chronic schizophrenia studied with positive emission tomography. Am J Psychiatry. 2000, 157: 542-548. 10.1176/appi.ajp.157.4.542.PubMed
163.
go back to reference Miller D, Rezai K, Alliger R, Andreasen N: The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography. Biol Psychiatry. 1997, 41: 550-559. 10.1016/S0006-3223(96)00110-2.PubMed Miller D, Rezai K, Alliger R, Andreasen N: The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography. Biol Psychiatry. 1997, 41: 550-559. 10.1016/S0006-3223(96)00110-2.PubMed
164.
go back to reference Vaiva G, Llorca P, Dupont S, Cottencin O, Devos P, Mazas O, Rascle C, Steinling M, Goudemand M: Spect imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome. Psychiatry Res. 2002, 115: 37-48.PubMed Vaiva G, Llorca P, Dupont S, Cottencin O, Devos P, Mazas O, Rascle C, Steinling M, Goudemand M: Spect imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome. Psychiatry Res. 2002, 115: 37-48.PubMed
165.
go back to reference Lahti A, Holcomb H, Weiler M, Medoff D, Tamminga C: Functional effects of antipsychotic drugs: comparing clozapine and haloperidol. Biol Psychiatry. 2003, 53: 601-608. 10.1016/S0006-3223(02)01602-5.PubMed Lahti A, Holcomb H, Weiler M, Medoff D, Tamminga C: Functional effects of antipsychotic drugs: comparing clozapine and haloperidol. Biol Psychiatry. 2003, 53: 601-608. 10.1016/S0006-3223(02)01602-5.PubMed
166.
go back to reference Miller D, Andreasen N, O'Leary D, Watkins G, Boles Ponto L, Hichwa R: Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol Psychiatry. 2001, 49: 704-715. 10.1016/S0006-3223(00)01001-5.PubMed Miller D, Andreasen N, O'Leary D, Watkins G, Boles Ponto L, Hichwa R: Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia. Biol Psychiatry. 2001, 49: 704-715. 10.1016/S0006-3223(00)01001-5.PubMed
167.
go back to reference Lahti A, H Holcomb, Medoff D, Weiler M, Tamminga C, Carpenter W: Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. Am J Psychiatry. 2001, 158: 1797-1808. 10.1176/appi.ajp.158.11.1797.PubMed Lahti A, H Holcomb, Medoff D, Weiler M, Tamminga C, Carpenter W: Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. Am J Psychiatry. 2001, 158: 1797-1808. 10.1176/appi.ajp.158.11.1797.PubMed
168.
go back to reference Vaiva G, Cottencin O, Llorca P, Devos P, Dupont S, Mazas O, Tascle C, Thomas P, Steinling M, Goudemand M: Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria. Prog Neuropsychopharmacol Biol Psychiatry. 2002, 26: 481-485. 10.1016/S0278-5846(01)00292-5.PubMed Vaiva G, Cottencin O, Llorca P, Devos P, Dupont S, Mazas O, Tascle C, Thomas P, Steinling M, Goudemand M: Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria. Prog Neuropsychopharmacol Biol Psychiatry. 2002, 26: 481-485. 10.1016/S0278-5846(01)00292-5.PubMed
169.
go back to reference Ashton L, Barnes A, Livingston M, Wyper D: Cingulate abnormalities associated with PANSS negative scores in first episode schizophrenia. Behav Neurol. 2000, 12: 93-101.PubMed Ashton L, Barnes A, Livingston M, Wyper D: Cingulate abnormalities associated with PANSS negative scores in first episode schizophrenia. Behav Neurol. 2000, 12: 93-101.PubMed
170.
go back to reference Franck N, O'Leary D, Flaum M, Hichwa R, Andreasen N: Cerebral blood flow changes associated with Schneiderian first-rank symptoms in schizophrenia. J Neuropsychiatry Clin Neurosci. 2002, 14: 277-282.PubMed Franck N, O'Leary D, Flaum M, Hichwa R, Andreasen N: Cerebral blood flow changes associated with Schneiderian first-rank symptoms in schizophrenia. J Neuropsychiatry Clin Neurosci. 2002, 14: 277-282.PubMed
171.
go back to reference Paradiso S, Andreasen N, Crespo-Facorro B, O'Leary D, Watkins G, Boles Ponto L, Hichwa R: Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am J Psychiatry. 2003, 160: 1175-1783. 10.1176/appi.ajp.160.10.1775. Paradiso S, Andreasen N, Crespo-Facorro B, O'Leary D, Watkins G, Boles Ponto L, Hichwa R: Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. Am J Psychiatry. 2003, 160: 1175-1783. 10.1176/appi.ajp.160.10.1775.
172.
go back to reference Meyer-Lindberg A, Miletich R, Kohn P, Esposito G, Carson R, Quarantelli M, D W, Berman K: Reduced prefrontal activity predicts exaggerated striatal dopominergic function in schizophrenia. Nat Neurosci. 2002, 5: 267-271. 10.1038/nn804. Meyer-Lindberg A, Miletich R, Kohn P, Esposito G, Carson R, Quarantelli M, D W, Berman K: Reduced prefrontal activity predicts exaggerated striatal dopominergic function in schizophrenia. Nat Neurosci. 2002, 5: 267-271. 10.1038/nn804.
173.
go back to reference Callicott J, Bertolino A, Mattay V, Langheim F, Duyn J, Coppola R, Goldberg T, Weinberger D: Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex. 2000, 10: 1078-1092. 10.1093/cercor/10.11.1078.PubMed Callicott J, Bertolino A, Mattay V, Langheim F, Duyn J, Coppola R, Goldberg T, Weinberger D: Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex. 2000, 10: 1078-1092. 10.1093/cercor/10.11.1078.PubMed
174.
go back to reference Sabri O, Owega A, Schreckenberger M, Sturz L, Fimm B, Kunert P, Meyer P, Sander D, Klingelhofer J: A truly simultaneous combination of functional transcranial doppler sonography and H2 15O PET adds fundamental new information on differences in cognitive activation between schizophrenics and healthy control subjects. J Nucl Med. 2003, 44: 671-681.PubMed Sabri O, Owega A, Schreckenberger M, Sturz L, Fimm B, Kunert P, Meyer P, Sander D, Klingelhofer J: A truly simultaneous combination of functional transcranial doppler sonography and H2 15O PET adds fundamental new information on differences in cognitive activation between schizophrenics and healthy control subjects. J Nucl Med. 2003, 44: 671-681.PubMed
175.
go back to reference Busatto GF, Zamignani DR, Buchpiguel CA, Garrido GE, Glabus MF, Rocha ET, Maia AF, Rosario-Campos MC, Campi Castro C, Furuie SS, et al: A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res. 2000, 99: 15-27.PubMed Busatto GF, Zamignani DR, Buchpiguel CA, Garrido GE, Glabus MF, Rocha ET, Maia AF, Rosario-Campos MC, Campi Castro C, Furuie SS, et al: A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res. 2000, 99: 15-27.PubMed
176.
go back to reference Lesser IM, Mena I, Boone KB, Miller BL, Mehringer CM, Wohl M: Reduction of cerebral blood flow in older depressed patients. Arch Gen Psychiatry. 1994, 51: 677-686.PubMed Lesser IM, Mena I, Boone KB, Miller BL, Mehringer CM, Wohl M: Reduction of cerebral blood flow in older depressed patients. Arch Gen Psychiatry. 1994, 51: 677-686.PubMed
177.
go back to reference Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P: Unmasking disease-specific cerebral blood flow abnormalities: Mood challenge in patients with remitted unipolar depression. Am J Psychiatry. 2002, 159: 1830-1840. 10.1176/appi.ajp.159.11.1830.PubMed Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P: Unmasking disease-specific cerebral blood flow abnormalities: Mood challenge in patients with remitted unipolar depression. Am J Psychiatry. 2002, 159: 1830-1840. 10.1176/appi.ajp.159.11.1830.PubMed
178.
go back to reference Swedo S, et al: High prevalence of obsessive-compulsive symptoms in patients with Sydenham's Chorea. Am J Psychiatry. 1989, 146: 246-249.PubMed Swedo S, et al: High prevalence of obsessive-compulsive symptoms in patients with Sydenham's Chorea. Am J Psychiatry. 1989, 146: 246-249.PubMed
179.
go back to reference Swedo SE, Leonard HL, Kiessling LS: Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics. 1994, 93: 323-326.PubMed Swedo SE, Leonard HL, Kiessling LS: Speculations on antineuronal antibody-mediated neuropsychiatric disorders of childhood. Pediatrics. 1994, 93: 323-326.PubMed
180.
go back to reference Asbahr F, Negrao A, Gentil V, Zanetta D, da Paz J, Marques-Dias M, Kiss M: Obsessive compulsive and related syndromes in children and adolescents with rheumatic fever with and without chorea: a prospective 6 month study. Am J Psychiatry. 1998, 155: 1122-1124.PubMed Asbahr F, Negrao A, Gentil V, Zanetta D, da Paz J, Marques-Dias M, Kiss M: Obsessive compulsive and related syndromes in children and adolescents with rheumatic fever with and without chorea: a prospective 6 month study. Am J Psychiatry. 1998, 155: 1122-1124.PubMed
181.
go back to reference Garvey MA, Swedo SE: PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever. J Child Neurol. 1998, 13: 413-423.PubMed Garvey MA, Swedo SE: PANDAS: the search for environmental triggers of pediatric neuropsychiatric disorders. Lessons from rheumatic fever. J Child Neurol. 1998, 13: 413-423.PubMed
182.
go back to reference Bottas A, Richer MA: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Pediatr Infect Dis J. 2002, 21: 67-71.PubMed Bottas A, Richer MA: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS). Pediatr Infect Dis J. 2002, 21: 67-71.PubMed
183.
go back to reference Moore D: Neuropsychiatric aspects of Sydenham's Chorea. J Clin Psychiatry. 1996, 57: 407-414.PubMed Moore D: Neuropsychiatric aspects of Sydenham's Chorea. J Clin Psychiatry. 1996, 57: 407-414.PubMed
184.
go back to reference Mercadante M, Busatto GF, Lombroso P, Prado L, Rosario-Campos M, do Valle R, Marques-Dias M, Kiss M, Leckman J, Miguel EC: The psychiatric symptoms of rheumatic fever. Am J Psychiatry. 2000, 157: 2036-2038. 10.1176/appi.ajp.157.12.2036.PubMed Mercadante M, Busatto GF, Lombroso P, Prado L, Rosario-Campos M, do Valle R, Marques-Dias M, Kiss M, Leckman J, Miguel EC: The psychiatric symptoms of rheumatic fever. Am J Psychiatry. 2000, 157: 2036-2038. 10.1176/appi.ajp.157.12.2036.PubMed
185.
go back to reference Davison K, Bagley CR: Schizophrenia-like psychoses associated with organic disorders of the central nervous system: A review of the literature. Current Problems in Neuropsychiatry British Journal of Psychiatry Special Publication No. 4. Edited by: Herrington RN. 1969, Ashford, Kent: Headley Brothers Davison K, Bagley CR: Schizophrenia-like psychoses associated with organic disorders of the central nervous system: A review of the literature. Current Problems in Neuropsychiatry British Journal of Psychiatry Special Publication No. 4. Edited by: Herrington RN. 1969, Ashford, Kent: Headley Brothers
186.
go back to reference Van Der Horst L: Rheumatism and psychosis. Foli Psychiatr Neurol Neurochir Neerl. 1948, 1/2: 56-54. Van Der Horst L: Rheumatism and psychosis. Foli Psychiatr Neurol Neurochir Neerl. 1948, 1/2: 56-54.
187.
go back to reference Bruetsch W: The histopathology of the psychoses with subacute bacterial and chronic verrucose rheumatic endocarditis. Amer J Psychiatry. 1938, 95: 335-346. Bruetsch W: The histopathology of the psychoses with subacute bacterial and chronic verrucose rheumatic endocarditis. Amer J Psychiatry. 1938, 95: 335-346.
188.
go back to reference Winkelman N, Eckel JL: The brain in acute rheumatic fever. Arch Neurol Psychiatry. 1932, 844-870. Winkelman N, Eckel JL: The brain in acute rheumatic fever. Arch Neurol Psychiatry. 1932, 844-870.
189.
go back to reference Dublin W: Pathologic lesions of the brain associated with chronic rheumatic endocarditis and accompanied by psychosis. Dis Nerv Syst. 1941, 390-393. Dublin W: Pathologic lesions of the brain associated with chronic rheumatic endocarditis and accompanied by psychosis. Dis Nerv Syst. 1941, 390-393.
190.
go back to reference Bruetsch W: Rheumatic endarteritis of cerebral vessels: sequel of rheumatic fever. Trans Am Neurol Assoc. 1942, 68: 17-20. Bruetsch W: Rheumatic endarteritis of cerebral vessels: sequel of rheumatic fever. Trans Am Neurol Assoc. 1942, 68: 17-20.
191.
go back to reference Van Der Horst L: Rheuma und psychose. Arch Psychiatr Nervenkr. 1949, 181: 325-336. Van Der Horst L: Rheuma und psychose. Arch Psychiatr Nervenkr. 1949, 181: 325-336.
192.
go back to reference Lewis A, Minski L: Chorea and psychosis. Lancet. 1935, 536-538. 10.1016/S0140-6736(01)19452-3. Lewis A, Minski L: Chorea and psychosis. Lancet. 1935, 536-538. 10.1016/S0140-6736(01)19452-3.
193.
go back to reference Skvortsova E: Clinical neuropsychiatric changes during rheumatism. Klin Med. 1956, 34: 32-25. Skvortsova E: Clinical neuropsychiatric changes during rheumatism. Klin Med. 1956, 34: 32-25.
194.
go back to reference Hammes E: Psychoses associated with Sydenham's Chorea. JAMA. 1922, 79: 804-807. Hammes E: Psychoses associated with Sydenham's Chorea. JAMA. 1922, 79: 804-807.
195.
go back to reference Howie D: Some pathological findings in schizophrenics. Am J Psychiatry. 1960, 117: 59-62.PubMed Howie D: Some pathological findings in schizophrenics. Am J Psychiatry. 1960, 117: 59-62.PubMed
196.
go back to reference Shaskan D: Mental changes in chorea minor. Am J Psychiatry. 1938, 95: 193-202. Shaskan D: Mental changes in chorea minor. Am J Psychiatry. 1938, 95: 193-202.
197.
go back to reference Bruetsch W: Chronic rheumatic brain disease as a possible factor in the causation of some cases of dementia praecox. Am J Psychiatry. 1940, 97: 276-296. Bruetsch W: Chronic rheumatic brain disease as a possible factor in the causation of some cases of dementia praecox. Am J Psychiatry. 1940, 97: 276-296.
198.
go back to reference Keeler WR, Bender L: A follow-up study of children with behavior disorders and Sydenham's chorea. Am J Psychiatry. 1952, 169: 421-428. Keeler WR, Bender L: A follow-up study of children with behavior disorders and Sydenham's chorea. Am J Psychiatry. 1952, 169: 421-428.
199.
go back to reference Wertheimer N: A psychiatric follow-up of children with rheumatic fever and other chronic diseases. J Chronic Dis. 1963, 16: 223-237. 10.1016/0021-9681(63)90028-6.PubMed Wertheimer N: A psychiatric follow-up of children with rheumatic fever and other chronic diseases. J Chronic Dis. 1963, 16: 223-237. 10.1016/0021-9681(63)90028-6.PubMed
200.
go back to reference Wilcox J, Nasrallah H: Sydenham's chorea and psychopathology. Neuropsychobiology. 1988, 19: 6-8.PubMed Wilcox J, Nasrallah H: Sydenham's chorea and psychopathology. Neuropsychobiology. 1988, 19: 6-8.PubMed
201.
go back to reference Guttmann E: On some constitutional aspects of chorea and on its sequelae. Journal of Neurology and Psychopathology. 1936, 17: 16-26.PubMedPubMedCentral Guttmann E: On some constitutional aspects of chorea and on its sequelae. Journal of Neurology and Psychopathology. 1936, 17: 16-26.PubMedPubMedCentral
202.
go back to reference Bruetsch W: Late cerebral sequele of rheumatic fever. Arch Intern Med. 1944, 73: 972-982. Bruetsch W: Late cerebral sequele of rheumatic fever. Arch Intern Med. 1944, 73: 972-982.
203.
go back to reference Wertheimer N: "Rheumatic schizophrenia". Arch Gen Psychiatry. 1961, 4: 579-596.PubMed Wertheimer N: "Rheumatic schizophrenia". Arch Gen Psychiatry. 1961, 4: 579-596.PubMed
204.
go back to reference Wilcox J, Nasrallah H: Sydenham's chorea and psychosis. Neuropsychobiology. 1986, 15: 13-14.PubMed Wilcox J, Nasrallah H: Sydenham's chorea and psychosis. Neuropsychobiology. 1986, 15: 13-14.PubMed
205.
go back to reference Hanson DR: Streptococcal infections and psychoses? A preliminary inquiry. Infectious Diseases and Neuropsychiatric Disorders. Edited by: Fatemi SH. 2005, London: Martin Dunitz Hanson DR: Streptococcal infections and psychoses? A preliminary inquiry. Infectious Diseases and Neuropsychiatric Disorders. Edited by: Fatemi SH. 2005, London: Martin Dunitz
206.
go back to reference Costero I: Cerebral lesions responsible for death of patients with active rheumatic fever. Arch Neurol Psychiatry. 1949, 62: 48-72.PubMed Costero I: Cerebral lesions responsible for death of patients with active rheumatic fever. Arch Neurol Psychiatry. 1949, 62: 48-72.PubMed
207.
go back to reference Bompiani G, Benedetti E, Cecconi D: Arteriopathie cerebrali reumatiche. Arch Ital Anat Istol Pathol. 1954, 28: 1-35. Bompiani G, Benedetti E, Cecconi D: Arteriopathie cerebrali reumatiche. Arch Ital Anat Istol Pathol. 1954, 28: 1-35.
208.
go back to reference Bini L, Giovanni M: Uber den chronischen cerebralrheumatismus. Arch Psychiat Nervenkr. 1952, 188: 261-273. 10.1007/BF00947044.PubMed Bini L, Giovanni M: Uber den chronischen cerebralrheumatismus. Arch Psychiat Nervenkr. 1952, 188: 261-273. 10.1007/BF00947044.PubMed
209.
go back to reference Mitkov V: Cerebral manifestations of rheumatic fever. World Neurol. 1961, 2: 920-927.PubMed Mitkov V: Cerebral manifestations of rheumatic fever. World Neurol. 1961, 2: 920-927.PubMed
210.
go back to reference Mueller N, Ackenheil M: Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: Relationship to negative symptomatology. Schizophr Res. 1995, 14: 223-228. 10.1016/0920-9964(94)00045-A. Mueller N, Ackenheil M: Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: Relationship to negative symptomatology. Schizophr Res. 1995, 14: 223-228. 10.1016/0920-9964(94)00045-A.
211.
go back to reference Carreno-Manjarrez R, Visvanathan K, Zabriskie J: Immunogenic and genetic factors in rheumatic fever. Curr Infect Dis Rep. 2000, 2: 302-307.PubMed Carreno-Manjarrez R, Visvanathan K, Zabriskie J: Immunogenic and genetic factors in rheumatic fever. Curr Infect Dis Rep. 2000, 2: 302-307.PubMed
212.
go back to reference Fish B: Neurobiologic antecedents of schizophrenia in children: Evidence for an inherited, congenital neurointegrative defect. Arch Gen Psychiatry. 1977, 34: 1297-1313.PubMed Fish B: Neurobiologic antecedents of schizophrenia in children: Evidence for an inherited, congenital neurointegrative defect. Arch Gen Psychiatry. 1977, 34: 1297-1313.PubMed
213.
go back to reference Meehl P: Schizotaxia, schizotypy, schizophrenia. Am Psychol. 1962, 17: 827-838. Meehl P: Schizotaxia, schizotypy, schizophrenia. Am Psychol. 1962, 17: 827-838.
215.
go back to reference Prabakaran S, Swatton J, Ryan M, Huffaker S, Huang J, Griffin J, Wayland M, Freeman T, Dudbridge F, Lilley K, et al: Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. 2004, 9: 684-697. Epub Apr 20PubMed Prabakaran S, Swatton J, Ryan M, Huffaker S, Huang J, Griffin J, Wayland M, Freeman T, Dudbridge F, Lilley K, et al: Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. 2004, 9: 684-697. Epub Apr 20PubMed
216.
go back to reference Yao J, Reddy R, van Kammen D: Oxidative damage and schizophrenia: an overview of the evidence. CNS Drugs. 2001, 15: 287-310.PubMed Yao J, Reddy R, van Kammen D: Oxidative damage and schizophrenia: an overview of the evidence. CNS Drugs. 2001, 15: 287-310.PubMed
217.
go back to reference Mahadik S, Scheffer R: Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 1996, 55: 45-54. 10.1016/S0952-3278(96)90144-1.PubMed Mahadik S, Scheffer R: Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot Essent Fatty Acids. 1996, 55: 45-54. 10.1016/S0952-3278(96)90144-1.PubMed
218.
go back to reference Mooradian A: The antioxidative potential of cerebral microvessels in experimental diabetes mellitus. Brain Res. 1995, 671: 164-169. 10.1016/0006-8993(94)01327-E.PubMed Mooradian A: The antioxidative potential of cerebral microvessels in experimental diabetes mellitus. Brain Res. 1995, 671: 164-169. 10.1016/0006-8993(94)01327-E.PubMed
219.
go back to reference Calingasan N, Park L, Calo L, Trifiletti R, Gandy S, Gibson G: Induction of nitric oxide synthase and microglial response precede selective cell death induced by chronic impairment of oxidative metabolism. Am J Pathol. 1998, 153: 599-610.PubMedPubMedCentral Calingasan N, Park L, Calo L, Trifiletti R, Gandy S, Gibson G: Induction of nitric oxide synthase and microglial response precede selective cell death induced by chronic impairment of oxidative metabolism. Am J Pathol. 1998, 153: 599-610.PubMedPubMedCentral
220.
go back to reference Mooradian A, Akon U: Age-related changes in the antioxidative potential of cerebral microvessels. Brain Res. 1995, 671: 159-163. 10.1016/0006-8993(94)01326-D.PubMed Mooradian A, Akon U: Age-related changes in the antioxidative potential of cerebral microvessels. Brain Res. 1995, 671: 159-163. 10.1016/0006-8993(94)01326-D.PubMed
221.
go back to reference Schwarz M, Ackenheil M, Riedel M, Mueller N: Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia. Neurosci Lett. 1998, 253: 201-203. 10.1016/S0304-3940(98)00655-7.PubMed Schwarz M, Ackenheil M, Riedel M, Mueller N: Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia. Neurosci Lett. 1998, 253: 201-203. 10.1016/S0304-3940(98)00655-7.PubMed
222.
go back to reference Buka S, Tsuang M, Fuller-Torrey E, Klebanoff M, Bernstein D, Yolken R: Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry. 2001, 58: 1032-1037. 10.1001/archpsyc.58.11.1032.PubMed Buka S, Tsuang M, Fuller-Torrey E, Klebanoff M, Bernstein D, Yolken R: Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry. 2001, 58: 1032-1037. 10.1001/archpsyc.58.11.1032.PubMed
223.
go back to reference Zornberg G, Buka S, Tsuang M: Hypoxia-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. Am J Psychiatry. 2000, 157: 196-202. 10.1176/appi.ajp.157.2.196.PubMed Zornberg G, Buka S, Tsuang M: Hypoxia-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: a 19-year longitudinal study. Am J Psychiatry. 2000, 157: 196-202. 10.1176/appi.ajp.157.2.196.PubMed
224.
go back to reference Brown A, Hooton J, Schaefer C, Zhang H, Petkova E, Babulas V, Perrin M, Gorman J, Susser E: Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry. 2004, 161: 889-895. 10.1176/appi.ajp.161.5.889.PubMed Brown A, Hooton J, Schaefer C, Zhang H, Petkova E, Babulas V, Perrin M, Gorman J, Susser E: Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry. 2004, 161: 889-895. 10.1176/appi.ajp.161.5.889.PubMed
225.
go back to reference Findlay G, Harris W: The topology of hair streams and whorls in man, with an observation on their relationship to epidermal ridge patterns. Am J Phys Anthropol. 1977, 46: 427-437.PubMed Findlay G, Harris W: The topology of hair streams and whorls in man, with an observation on their relationship to epidermal ridge patterns. Am J Phys Anthropol. 1977, 46: 427-437.PubMed
226.
go back to reference Furdon S, Clark D: Scalp hair characteristics in the newborn infant. Adv Neonatal Care. 2003, 3: 286-296. 10.1016/j.adnc.2003.09.005.PubMed Furdon S, Clark D: Scalp hair characteristics in the newborn infant. Adv Neonatal Care. 2003, 3: 286-296. 10.1016/j.adnc.2003.09.005.PubMed
227.
go back to reference Detmar M, Brown L, B B, Jackman R, Elicker B, Dvorak H, Claffey K: Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol. 1997, 108: 263-268. 10.1111/1523-1747.ep12286453.PubMed Detmar M, Brown L, B B, Jackman R, Elicker B, Dvorak H, Claffey K: Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol. 1997, 108: 263-268. 10.1111/1523-1747.ep12286453.PubMed
228.
go back to reference Futamura T, Toyooka K, Iritani S, Nilzato K, Nakamura R, Tsuchiya K, Someya T, Kakita A, Takahashi H, Nawa H: Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol Psychiatry. 2002, 7: 673-682. 10.1038/sj.mp.4001081.PubMed Futamura T, Toyooka K, Iritani S, Nilzato K, Nakamura R, Tsuchiya K, Someya T, Kakita A, Takahashi H, Nawa H: Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol Psychiatry. 2002, 7: 673-682. 10.1038/sj.mp.4001081.PubMed
229.
go back to reference Merrill JT: Regulation of the vasculature: clues from lupus. Curr Opin Rheumatol. 2002, 14: 504-509. 10.1097/00002281-200209000-00004.PubMed Merrill JT: Regulation of the vasculature: clues from lupus. Curr Opin Rheumatol. 2002, 14: 504-509. 10.1097/00002281-200209000-00004.PubMed
230.
go back to reference Ekdahl CT, Claasen J-H, Bonde S, Kokaia Z, Lindvall O: Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci USA. 2003, 100: 13632-13637. 10.1073/pnas.2234031100.PubMedPubMedCentral Ekdahl CT, Claasen J-H, Bonde S, Kokaia Z, Lindvall O: Inflammation is detrimental for neurogenesis in adult brain. Proc Natl Acad Sci USA. 2003, 100: 13632-13637. 10.1073/pnas.2234031100.PubMedPubMedCentral
231.
go back to reference Dinc A, Melikoglu M, Korkmaz C, Fresko I, Ozdogan H, Yazidi H: Nailfold capillary abnormalities in patients with familial Mediterranean fever. Clin Exp Rheumatol. 2001, 19: s42-s44.PubMed Dinc A, Melikoglu M, Korkmaz C, Fresko I, Ozdogan H, Yazidi H: Nailfold capillary abnormalities in patients with familial Mediterranean fever. Clin Exp Rheumatol. 2001, 19: s42-s44.PubMed
232.
go back to reference den Broeder A, van den Hoogren F, van de Putte L: Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumor necrosis factor alpha blocking treatment. Ann Rheum Dis. 2001, 60: 538-539. 10.1136/ard.60.5.538.PubMedPubMedCentral den Broeder A, van den Hoogren F, van de Putte L: Isolated digital vasculitis in a patient with rheumatoid arthritis: good response to tumor necrosis factor alpha blocking treatment. Ann Rheum Dis. 2001, 60: 538-539. 10.1136/ard.60.5.538.PubMedPubMedCentral
233.
go back to reference Stollerman GH: Rheumatic fever. Lancet. 1997, 349: 935-942. 10.1016/S0140-6736(96)06364-7.PubMed Stollerman GH: Rheumatic fever. Lancet. 1997, 349: 935-942. 10.1016/S0140-6736(96)06364-7.PubMed
234.
go back to reference Bisno A, Pearce I, Wall H, Moody M, Stollerman GH: Contrasting epidemiology of acute glomerulonephritis: nature of the antecedent streprococcal infection. N Engl J Med. 1970, 283: 561-565.PubMed Bisno A, Pearce I, Wall H, Moody M, Stollerman GH: Contrasting epidemiology of acute glomerulonephritis: nature of the antecedent streprococcal infection. N Engl J Med. 1970, 283: 561-565.PubMed
235.
go back to reference Smoot J, Barbian K, Van Gompel J, Smoot L, Chaussee M, Sylva G, Sturdevant D, Ricklefs S, Porcella S, Parkins L, et al: Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA. 2002, 99: 4668-4673. 10.1073/pnas.062526099.PubMedPubMedCentral Smoot J, Barbian K, Van Gompel J, Smoot L, Chaussee M, Sylva G, Sturdevant D, Ricklefs S, Porcella S, Parkins L, et al: Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci USA. 2002, 99: 4668-4673. 10.1073/pnas.062526099.PubMedPubMedCentral
236.
go back to reference Boin F, Zanardini R, Pioli R, Altamura C, Maes M, Gennarelli M: Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry. 2001, 6: 79-82. 10.1038/sj.mp.4000815.PubMed Boin F, Zanardini R, Pioli R, Altamura C, Maes M, Gennarelli M: Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry. 2001, 6: 79-82. 10.1038/sj.mp.4000815.PubMed
237.
go back to reference Schwab S, Mondabon S, Knapp M, Albus M, Hallmayer J, Borrmann-Hassenbach M, Trixler M, Gross M, Schulze T, Rietschel M, et al: Association of tumor necrosis factor alpha gene -G308A polymorphisms with schizophrenia. Schizophr Res. 2003, 65: 19-25. 10.1016/S0920-9964(02)00534-0.PubMed Schwab S, Mondabon S, Knapp M, Albus M, Hallmayer J, Borrmann-Hassenbach M, Trixler M, Gross M, Schulze T, Rietschel M, et al: Association of tumor necrosis factor alpha gene -G308A polymorphisms with schizophrenia. Schizophr Res. 2003, 65: 19-25. 10.1016/S0920-9964(02)00534-0.PubMed
238.
go back to reference Katila H, Hanninen K, Hurme M: Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry. 1999, 4: 179-181. 10.1038/sj.mp.4000483.PubMed Katila H, Hanninen K, Hurme M: Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry. 1999, 4: 179-181. 10.1038/sj.mp.4000483.PubMed
239.
go back to reference Erbagci A, Herken H, Koyluoglu O, Yilmaz N, Tarakcioglu M: Serum IL-1beta, sIL-2r, IL-6, IL-8, and TNF alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators Inflamm. 2001, 10: 109-115. 10.1080/09629350120072761.PubMedPubMedCentral Erbagci A, Herken H, Koyluoglu O, Yilmaz N, Tarakcioglu M: Serum IL-1beta, sIL-2r, IL-6, IL-8, and TNF alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators Inflamm. 2001, 10: 109-115. 10.1080/09629350120072761.PubMedPubMedCentral
240.
go back to reference Moots R, Al-Saffer Z, Hutchinson D, Golding S, Young S, Bacon P, McLaughlin P: Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines. Ann Rheum Dis. 1999, 58: 585-587.PubMedPubMedCentral Moots R, Al-Saffer Z, Hutchinson D, Golding S, Young S, Bacon P, McLaughlin P: Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines. Ann Rheum Dis. 1999, 58: 585-587.PubMedPubMedCentral
241.
go back to reference Leykin I, Mayer R, Shinitzky M: Short and long-term immunosuppressive effects of clozapine and haloperidol. Immunopharmacology. 1997, 37: 75-86. 10.1016/S0162-3109(97)00037-4.PubMed Leykin I, Mayer R, Shinitzky M: Short and long-term immunosuppressive effects of clozapine and haloperidol. Immunopharmacology. 1997, 37: 75-86. 10.1016/S0162-3109(97)00037-4.PubMed
242.
go back to reference Maes M, Bocchio C, Bignotti S, Battisa T, Pioli R, Boin F, Kenix G, Bosmans E, de Jongh R, Lin A, et al: Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur Neuropsychopharmacol. 2000, 10: 119-124. 10.1016/S0924-977X(99)00062-0.PubMed Maes M, Bocchio C, Bignotti S, Battisa T, Pioli R, Boin F, Kenix G, Bosmans E, de Jongh R, Lin A, et al: Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics. Eur Neuropsychopharmacol. 2000, 10: 119-124. 10.1016/S0924-977X(99)00062-0.PubMed
243.
go back to reference Marek J: On the non-specific anitinflammatory effects of other-than-anitrheumatic drugs. Psychotropic drugs, inflammation and antiinflammatory drugs. Int J Tissue React. 1985, 7: 475-504.PubMed Marek J: On the non-specific anitinflammatory effects of other-than-anitrheumatic drugs. Psychotropic drugs, inflammation and antiinflammatory drugs. Int J Tissue React. 1985, 7: 475-504.PubMed
244.
go back to reference Rudolf S, Peters M, Rothermundt M, Arolt V, Kirchner H: The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interfreron-gamma in vitro. Neuropsychobiology. 2002, 46: 180-185. 10.1159/000067807.PubMed Rudolf S, Peters M, Rothermundt M, Arolt V, Kirchner H: The influence of typical and atypical neuroleptic drugs in the production of interleukin-2 and interfreron-gamma in vitro. Neuropsychobiology. 2002, 46: 180-185. 10.1159/000067807.PubMed
245.
go back to reference Mueller N, Riedel M, Scheppach C, Brandstatter B, Sokullu S, Krampe K, Ulmschneider M, Engel R, Moller H, Schwartz M: Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry. 2002, 159: 1029-1034. 10.1176/appi.ajp.159.6.1029. Mueller N, Riedel M, Scheppach C, Brandstatter B, Sokullu S, Krampe K, Ulmschneider M, Engel R, Moller H, Schwartz M: Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry. 2002, 159: 1029-1034. 10.1176/appi.ajp.159.6.1029.
246.
go back to reference McGuffin P, Asherson P, Owen M, Farmer A: The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia?. Br J Psychiatry. 1994, 164: 593-599.PubMed McGuffin P, Asherson P, Owen M, Farmer A: The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia?. Br J Psychiatry. 1994, 164: 593-599.PubMed
247.
go back to reference Moises H, Gottesman I: Genetics, risk factors, and personality factors. Contemporary Psychiatry. Edited by: Henn F, Helmchen H, Lauter H, Sartorius N. 2000, Heidelberg: Springer Verlag, 47-59. Moises H, Gottesman I: Genetics, risk factors, and personality factors. Contemporary Psychiatry. Edited by: Henn F, Helmchen H, Lauter H, Sartorius N. 2000, Heidelberg: Springer Verlag, 47-59.
248.
go back to reference Turkheimer E: Spinach and ice cream: why social science is so difficult. Behavior Genetics Principles: Perspective in Development, Personality, and Psychopathology. Edited by: DiLalla L. 2004, Washington, D.C.: American Psychological Association, 161-189. Turkheimer E: Spinach and ice cream: why social science is so difficult. Behavior Genetics Principles: Perspective in Development, Personality, and Psychopathology. Edited by: DiLalla L. 2004, Washington, D.C.: American Psychological Association, 161-189.
249.
250.
go back to reference Ehrenreich H, Degner D, Meller J, Brines M, Behe M, Hasselblatt M, Woldt H, Falki P, Knerlich F, Jacob S, et al: Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry. 2004, 1-13. Ehrenreich H, Degner D, Meller J, Brines M, Behe M, Hasselblatt M, Woldt H, Falki P, Knerlich F, Jacob S, et al: Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Mol Psychiatry. 2004, 1-13.
251.
go back to reference Tsao B, Grossman J, Riemekasten G, Strong N, Kalsi J, Wallace D, Chen C-J, Lau C, Ginzler E, Goldstein R, et al: Familiality and co-occurrence of clinical features of systemic lupus erythematosus. Arthritis Rheum. 2002, 46: 2678-2685. 10.1002/art.10519.PubMed Tsao B, Grossman J, Riemekasten G, Strong N, Kalsi J, Wallace D, Chen C-J, Lau C, Ginzler E, Goldstein R, et al: Familiality and co-occurrence of clinical features of systemic lupus erythematosus. Arthritis Rheum. 2002, 46: 2678-2685. 10.1002/art.10519.PubMed
252.
go back to reference Dysken M, Patlak C, Dobben G, Pettigrew K, Bartko J, Burns E, Davis J, Refier D: Rapid dynamic CT scanning to distinguish schizophrenic from normal subjects. Psychiatry Res. 1987, 20: 165-175.PubMed Dysken M, Patlak C, Dobben G, Pettigrew K, Bartko J, Burns E, Davis J, Refier D: Rapid dynamic CT scanning to distinguish schizophrenic from normal subjects. Psychiatry Res. 1987, 20: 165-175.PubMed
253.
go back to reference Mueller N, Ackenheil M: Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1998, 22: 1-33. 10.1016/S0278-5846(97)00179-6. Mueller N, Ackenheil M: Psychoneuroimmunology and the cytokine action in the CNS: Implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1998, 22: 1-33. 10.1016/S0278-5846(97)00179-6.
254.
go back to reference Harrison P, Weinberger D: Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005, 10: 40-68. 10.1038/sj.mp.4001558.PubMed Harrison P, Weinberger D: Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005, 10: 40-68. 10.1038/sj.mp.4001558.PubMed
255.
go back to reference Rosenthal D: Genetic Theory and Abnormal Behavior. 1970, New York: McGraw-Hill, 162-168. Rosenthal D: Genetic Theory and Abnormal Behavior. 1970, New York: McGraw-Hill, 162-168.
256.
go back to reference Schumacher J, Abon Jamra R, Freudenber J, Becker T, Ohiarun S, Otte A, Tullius M, Kovalenko S, Van Den Bogaert A, Maier W, et al: Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry. 2004, 9: 203-207.PubMed Schumacher J, Abon Jamra R, Freudenber J, Becker T, Ohiarun S, Otte A, Tullius M, Kovalenko S, Van Den Bogaert A, Maier W, et al: Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry. 2004, 9: 203-207.PubMed
257.
go back to reference Maziade M, Roy M-A, Chagnon Y, Cliche D, Fournier J-P, Montgrain N, Dion C, Lavallee J-C, Garneau Y, Gingras N, et al: Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a genome scan in Eastern Quebec families. Mol Psychiatry. 2004, Nov 9 (e-pub): 1-14. Maziade M, Roy M-A, Chagnon Y, Cliche D, Fournier J-P, Montgrain N, Dion C, Lavallee J-C, Garneau Y, Gingras N, et al: Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a genome scan in Eastern Quebec families. Mol Psychiatry. 2004, Nov 9 (e-pub): 1-14.
258.
go back to reference Rajkowska G: Cell pathology in bipolar disorder. Semin Clin Neuropsychiatry. 2002, 7: 281-292. 10.1053/scnp.2002.35228.PubMed Rajkowska G: Cell pathology in bipolar disorder. Semin Clin Neuropsychiatry. 2002, 7: 281-292. 10.1053/scnp.2002.35228.PubMed
259.
go back to reference Muller M, Lucassen P, Yassouridis H, Hoogendijk W, Holsboer F, Swaab D: Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci. 2001, 14: 1603-1612.PubMed Muller M, Lucassen P, Yassouridis H, Hoogendijk W, Holsboer F, Swaab D: Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci. 2001, 14: 1603-1612.PubMed
260.
go back to reference Gottesman I, Hanson D: Human Development: Biological and genetic processes. Annu Rev Psychol. 2005, 56: 263-286.PubMed Gottesman I, Hanson D: Human Development: Biological and genetic processes. Annu Rev Psychol. 2005, 56: 263-286.PubMed
262.
go back to reference Gottesman I, Gould T: The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003, 160: 636-645. 10.1176/appi.ajp.160.4.636.PubMed Gottesman I, Gould T: The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003, 160: 636-645. 10.1176/appi.ajp.160.4.636.PubMed
Metadata
Title
Theories of schizophrenia: a genetic-inflammatory-vascular synthesis
Authors
Daniel R Hanson
Irving I Gottesman
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2005
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-6-7

Other articles of this Issue 1/2005

BMC Medical Genetics 1/2005 Go to the issue